Skip to main content
Erschienen in: Journal of Medical Systems 1/2023

Open Access 01.12.2023 | Original Paper

Machine Learning for Dementia Prediction: A Systematic Review and Future Research Directions

verfasst von: Ashir Javeed, Ana Luiza Dallora, Johan Sanmartin Berglund, Arif Ali, Liaqata Ali, Peter Anderberg

Erschienen in: Journal of Medical Systems | Ausgabe 1/2023

Abstract

Nowadays, Artificial Intelligence (AI) and machine learning (ML) have successfully provided automated solutions to numerous real-world problems. Healthcare is one of the most important research areas for ML researchers, with the aim of developing automated disease prediction systems. One of the disease detection problems that AI and ML researchers have focused on is dementia detection using ML methods. Numerous automated diagnostic systems based on ML techniques for early prediction of dementia have been proposed in the literature. Few systematic literature reviews (SLR) have been conducted for dementia prediction based on ML techniques in the past. However, these SLR focused on a single type of data modality for the detection of dementia. Hence, the purpose of this study is to conduct a comprehensive evaluation of ML-based automated diagnostic systems considering different types of data modalities such as images, clinical-features, and voice data. We collected the research articles from 2011 to 2022 using the keywords dementia, machine learning, feature selection, data modalities, and automated diagnostic systems. The selected articles were critically analyzed and discussed. It was observed that image data driven ML models yields promising results in terms of dementia prediction compared to other data modalities, i.e., clinical feature-based data and voice data. Furthermore, this SLR highlighted the limitations of the previously proposed automated methods for dementia and presented future directions to overcome these limitations.
Hinweise
Ashir Javeed and Ana Luiza Dallora contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Over a period of time, the advancements made in the field of medical science helped to increase the lifespan in the modern world [1]. This increased life expectancy raised the prevalence of neurocognitive disorders, affecting a significant part of the older population as well as global economies. In 2010, it was estimated that $604 billion have been spent on dementia patients in the USA alone[2]. The number of dementia patients is rapidly increasing worldwide, and statistical projections suggest that 135 million people might be affected by dementia by 2050 [3]. There are several risk factors that contribute to the development of dementia, including aging, head injury, and lifestyle. While age is the most prominent risk factor for dementia; figures suggest that a person at the age of 65 years old has 1–2% risk of developing dementia disease. By the age of 85 years old, this risk can reach to 30% [4].
Dementia is a mental disorder that is characterized by a progressive deterioration of cognitive functions that can affect daily life activities such as memory, problem solving, visual perception, and the ability to focus on a particular task. Usually, older adults are most vulnerable to dementia, and people take it as an inevitable consequence of aging, which is perhaps the wrong perception. Dementia is not a part of the normal ageing process; however, it should be considered a serious form of cognitive decline that affects your daily life. Actually, the primary cause for the development of dementia is the several diseases and injuries that affect the human brain [5]. Dementia is ranked on the seventh place in the leading causes of deaths in the world [6]. Furthermore, it is the major cause of disability and dependency among older people globally [6]. A change in the person’s ordinary mental functioning and obvious signs of high cognitive deterioration are required for a diagnosis of dementia [7]. Figure 1 presents the progression of dementia with age.

Types of dementia

Dementia is not a single disease, but, it is used as a generic term for several different cognitive disorders. Figure 2 provides the overview of different types of dementia along with the percentage of particular dementia type occurrence in the patients [8]. To have a better idea about dementia, we have studied common types of dementia for better problem awareness.

Alzheimer’s disease

Alzheimer’s disease (AD) is thought to develop when abnormal amounts of amyloid beta (A\(\beta\)) build up in the brain, either extracellularly as amyloid plaques, tau proteins or intracellularly as neurofibrillary tangles, affecting neuronal function, connectivity and leading to progressive brain function loss [9]. This diminished ability to eliminate proteins with ageing is regulated by brain cholesterol [10] and is linked to other neurodegenerative illnesses [11]. Except for 1–2% of cases where deterministic genetic anomalies have been discovered, the aetiology of the majority of Alzheimer’s patients remains unexplained [12]. The amyloid beta (A\(\beta\)) hypothesis and the cholinergic hypothesis are two competing theories presented to explain the underlying cause of AD [13].

Vascular dementia

Vascular dementia (VaD) is a subtype of dementia caused by problems with the brain’s blood flow, generally in the form of a series of minor strokes, which results in a slow decline of cognitive capacity [14]. The VaD refers to a disorder characterized by a complicated mix of cerebrovascular illnesses that result in structural changes in the brain, as a result of strokes and lesions, which lead to cognitive impairment. A chronological relationship between stroke and cognitive impairments is necessary to make the diagnosis [15]. Ischemic or hemorrhagic infarctions in several brain areas, such as the anterior cerebral artery region, the parietal lobes, or the cingulate gyrus, are associated with VaD. In rare cases, infarcts in the hippocampus or thalamus might cause dementia [16]. A stroke increases the risk of dementia by 70%, whereas a recent stroke increases the risk by almost 120% [17]. Brain vascular lesions can also be caused by diffuse cerebrovascular disease, such as small vessel disease [18]. Risk factors for VaD include age, hypertension, smoking, hypercholesterolemia, diabetes mellitus, cardiovascular disease, and cerebrovascular sickness; geographic origin, genetic proclivity, and past strokes are also risk factors [19]. Cerebral amyloid angiopathy, which develops when beta amyloid accumulates in the brain, can occasionally lead to vascular dementia.

Lewy body dementia

Lewy body dementia (LBD) is a subtype of dementia characterized by abnormal deposits of the protein alpha-synuclein in the brain. These deposits, known as Lewy bodies, affect brain chemistry, causing problems with thinking, movement, behavior, and mood. Lewy body dementia is one of the most common causes of dementia [20]. Progressive loss of mental functions, visual hallucinations, as well as changes in alertness and concentration are prevalent in persons with LBD. Other adverse effects include tight muscles, delayed movement, difficulty walking, and tremors, all of which are also signs and symptoms of Parkinson’s disease [21]. LBD might be difficult to identify. Early LBD symptoms are commonly confused with those of other brain diseases or mental problems. Lewy body dementia can occur alone or in conjunction with other brain disorders [22]. It is a progressive disorder, which means that symptoms emerge gradually and worsen with time. A timespan of five to eight years is averaged, although it can last anywhere from two to twenty years for certain people [23]. The rate at which symptoms arise varies greatly from person to person, depending on overall health, age, and the severity of symptoms.

Frontotemporal dementia

Frontotemporal Dementia (FTD) is a subtype of dementia characterized by nerve cell loss in the frontal and temporal lobes of the brain [24]. As a result, the lobes contract. FTD can have an impact on behavior, attitude, language, and movement. This is one of the most common dementias in people under the age of 65. FTD most commonly affects persons between the ages of 40 and 65; however, it may also afflict young adults and older individuals [25]. The lobes decrease, and behavior, attitude, language, and mobility can all be affected by FTD. FTD affects both men and women equally. Dissociation from family, extreme oniomania, obscene speech, screaming, and the inability to regulate emotions, behavior, personality, and temperament are examples of social display patterns caused by FTD [26]. The symptoms of FTD appeared several years prior to visiting a neurologist [27].

Mixed Dementia (MD)

Mixed dementia occurs, when more than one kind of dementia coexists in a patient, and it is estimated to happen in around 10% of all dementia cases [6]. AD and VaD dementia are the two subtypes that are most common in MD [28]. This case is usually associated with factors such as old age, high blood pressure, and brain blood vessel damage [29]. Because one dementia subtype often predominates, MD is difficult to identify. As a result, the individuals affected by MD are rarely treated and miss out on potentially life-changing medicines. MD can cause symptoms to begin earlier than the actual diagnosis of the disease and spread swiftly to affect the most areas of the brain [30].

Method

Recently, numerous automated methods have been developed based on machine learning for early the prediction of different diseases [3148]. This systematic literature review (SLR) presented hereby, investigates machine learning-based automated diagnostic systems that are designed and developed by scientists to predict dementia and its subtypes, such as AD, VaD, LBD, FTD and MD. We used the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) criteria to conduct this SLR [49, 50]. A comprehensive search was conducted to retrieve the research articles that contain ML approaches to predict the development of dementia and its subtypes using three different types of data modalities (images, clinical-variables, voice).

Aim of the study

SLRs are done to synthesize current evidence, to identify gaps in the literature, and to provide the groundwork for future studies [51]. Previous, SLRs studies have been done on automated diagnostic systems for dementia prediction based on ML approaches, which focused on a single sort of data modality. These SLR investigations did not emphasize the limits of previously published automated approaches for dementia prediction. The SLR presented herein assesses the previously proposed automated diagnostic systems based on deep learning (DL) and ML algorithms for the prediction of dementia and its common subtypes (e.g. AD, VaD, FTD, MD). The aim of this SLR is to analyse and evaluate the performance of automated diagnostic systems for dementia prediction using different data modalities. The main question is decomposed in the following sub-research questions:
1.
What types of ML and DL techniques have been used by researchers to diagnose dementia?
 
2.
Examine the methods of feature extraction or selection used by the researchers.
 
3.
Analyze the different performance evaluation measures that are adopted by the researcher to validate the effectiveness of the proposed diagnostic system for demetnia.
 
4.
Analyze the performance of ML models on various data types.
 
5.
Identification of weaknesses in previously proposed ML models for dementia prediction.
 

Article selection

For this SLR study, the research articles were selected based on keywords such as ML, DL, dementia and its subtypes (AD, VaD, FTD, and MD). For the collection of research articles, we conducted an electronic search from different online databases such as ScienceDirect, PubMed, IEEE Xplore Digital Library, Springer, Hindawi, and PLOs, which helped to gather 450 research studies on the specific topic. After reviewing the title and abstract in each study, 120 publications were found to be ineligible for processing, while 330 articles were selected for further processing. Following the deduplication of data, 125 full-text publications were retrieved for further processing after the screening phase of the article selection, with 205 of them being eliminated due to not satisfying the article selection criteria of the screening phase. Finally, 50 research articles were eliminated due to not fulfilling the eligibility criteria for article selection. The final set of selected papers consisted of 75 research papers, among these final selected articles, each of the data modalities (image, clinical-variables, voice) contained 25 papers. After rerunning the database searches in May 2022, no further suitable research article was found for the selection. Figure 3 presents the workflow for article selection, which includes the four PRISMA guidelines-recommended steps such as identification, screening, eligibility, and inclusion [49, 50]. In recent years, ML scientists have shown a strong interest in designing and developing ML-based automated diagnostic systems for dementia prediction. Therefore, the number of research articles in this research area has been increased and it can be depicted from Fig. 4 where research articles are published years wise with regarding data modality. The publications utilized in this study were selected based on the following criteria:
1.
Studies that present automated diagnostic systems for dementia and its common subtypes (AD,VaD, FTD, MD).
 
2.
Studies published between 2011 and 2022.
 
3.
Studies employing ML approaches for dementia diagnosis.
 
4.
Studies which have utilized several data modalities.
 
5.
Studies published in the English language.
 

Machine learning for dementia

Over the years, the increasing use and availability of medical equipment has resulted in a massive collection of electronic health records (EHR) that might be utilized to identify dementia using developing technologies such as ML and DL [52]. These EHRs are one of the most widely available and used clinical datasets. They are a crucial component of contemporary healthcare delivery, providing rapid access to accurate, up-to-date, comprehensive patient information while also assisting with precise diagnosis and coordinated, efficient care [53]. Laboratory tests, vital signs, drugs, and other therapies, as well as comorbidities, can be used to identify the people at risk of dementia using the EHRs’ data [54]. In some situations, patients may also be subjected to costly and invasive treatments such as neuroimaging scans i.e., magnetic resonance imaging (MRI) and position emission tomography (PET)) and cerebrospinal fluid (CSF) collection for biomarker testing [5557]. These tests’ findings may also be found in the EHR. According to researchers, such longitudinal clinical EHR data can be used to track the advancement of AD dementia over time [58]. Recently, several automated diagnostic systems for different diseases, such as Parkinson’s disease [59], hepatitis [47], carcinoma [41], and heart failure [6062] prediction have been designed by employing ML and DL techniques. Inspired by this fact, the unmet demand for dementia knowledge, along with the availability of relevant huge datasets, has motivated scientists to investigate the utility of artificial intelligence (AI), which is gaining a prominent role in the area of healthcare innovation [63]. ML, a subset of AI, can model the relationship between input quantities and clinical outcomes, identify hidden patterns in enormous volumes of data, and draw conclusions or make decisions that help with more accurate clinical decision-making [51]. However, computational hypotheses generated by ML models must still be confirmed by subject matter experts in order to achieve enough precision for clinical decision-making [64].
In this SLR, we have included studies that have used ML predictive models (supervised and unsupervised) for dementia prediction and excluded studies that have used statistical methods for cohort summarization and hypothesis testing (e.g., odds ratio, chi-square distribution, Kruskal-Wallis test, and Kappa-Cohen test). Furthermore, we have referenced the data modality-based study [65] for this literature review, where we have categorized the three data modality types such as image, clinical-variable and voice. Thus, we have studied each modality-based automated diagnostic system for dementia prediction that has been proposed in the past using ML and DL.
Table 1
Summary of image-modality based datasets
Dataset_ID
Dataset
Samples
Variables
Dementia_Type
01
NA
373
5
AD
02
ADNI
300
4
AD
03
ALZ201
72
4
AD
04
ADNI
138
6
AD
05
NINDS-AIREN
93
62
VaD, AD
06
OASIS
373
8
AD
07
OASIS-1
216
10
AD
08
OASIS-2
373
12
AD
09
ADNI
273
8
AD
10
OASIS
420
5
AD
11
ADNI
750
10
AD
12
NA
373
15
AD
13
ADNI
506
7
AD
14
OASIS
436
NA
Dementia
15
ADNI
750
10
AD
16
OASIS
373
8
AD

Datasets

This section explains the datasets that were used in the selected research papers for experiments and performance evaluation of the proposed automated diagnostic systems designed by the researchers using ML algorithms for dementia and its subtypes. A total of 61 datasets were studied from the selected research articles. These datasets are compiled from a wide range of organizations and hospitals throughout the world. Only a few datasets are openly available to the public, while others are compiled by researchers from various hospitals and healthcare institutes. We have only included datasets that have been used to diagnose AD, VaD, FTD, MD, and LBD using ML and DL techniques. On the basis of data modality, we have categorised the dataset into three types: images, clinical_variables and voice datasets. The datasets differ in terms of the number of variables (features) and samples. As a result, we examined each modality of the dataset one by one.

Image modality based datasets

There are several image datasets based on brain imaging, such as magnetic resonance imaging (MRI), collected by the researchers for the diagnosis of dementia. From the Table 1, it can be depicted that Open Access Series of Imaging Studies (OASIS) and Alzheimer’s Disease Neuroimaging Initiative (ADNI) datasets are mostly used by the researchers for the experimental purpose. OASIS aims to make neuroimaging datasets available to the scientific community for free. By gathering and openly disseminating this multimodal dataset produced by the Knight ADRC and its related researchers, they had used different samples and variables of the datasets in their research work. ADNI researchers acquire, validate, and use data such as MRI, PET imaging, genetics, cognitive assessments, CSF, and blood biomarkers as disease predictors. The ADNI website contains research information and data from the North American ADNI project, which includes Alzheimer’s disease patients, people with mild cognitive impairment, and older controls. Table 1 provides us with the following information: dataset_id, dataset name, number of samples in the particular dataset, variables in the dataset, and finally, the type of dementia.
Table 2
Summary of clinical-variable modality based datasets
Dataset_ID
Dataset
Samples
Variables
Dementia_Type
17
HAICDDS
1354
45
MD
18
Adnimerge
1851
49
MD
19
EMIF-AD cohort
500
4
AD
20
OASIS
373
10
Dementia
21
ADRD
44945
50
Dementia
22
multi-sensor
17
13
Dementia
23
Bremen-Ost
158
7
MCI, AD
24
microRNA
39
25
AD
25
Raman spectral
37
360
AD
26
Cheng Kung
81
10
AD
27
NA
169
14
Dementia
28
LASI-DAD
2528
30
Dementia
29
NACC
15307
258
Dementia
30
NCT
138
15
Dementia
31
Lebanon
1002
20
Dementia
32
FDG-PET
329
32
AD
33
OASIS
450
NA
AD
34
LOHAS
123
40
Dementia
35
GIST
60
6
MCI
36
ADRD
1038
35
Dementia
37
HRS
9979
52
Dementia
38
MCSA
3265
36
MD
39
MNCD
84
38
AD,FTD

Clinical-variables modality based datasets

Throughout the course of time, the growing usage and availability of medical devices have resulted in an overwhelming collection of clinical EHR data. Furthermore, the patient’s medical history consists of medical tests and clinical records that can be used for the prediction of diseases. Thus, the importance of clinical data emerges as a vital tool for proactive management of disease. The dataset based on clinical variables for dementia consists of medical tests that are used by doctors to check the dementia status in patients, such as the Mini Mental Status Exam (MMSE), the Montreal Cognitive Assessment (MoCA), the Telephone Interview for Cognitive Status (TICS), and the Brief Interview for Mental Status (BIMS). Clinical-variables based datasets consist of information about these medical tests along with patient personal information, i.e., age, sex, and marital status. Hereby, Table 2 provides the information regarding clinical-variables modality-based datasets that are used by the researchers for the design and development of automated diagnostic systems for dementia patients based on ML. Table 2 presents the dataset_id, dataset name, number of samples in the particular dataset, variables in the dataset, and finally the type of dementia.

Voice modality based datasets

Speech analysis is a useful technique for clinical linguists in detecting various types of neurodegenerative disorders affecting the language processing areas. Individuals suffering from Parkinson’s disease (PD, deterioration of voice quality, unstable pitch), Alzheimer’s disease (AD, monotonous pitch), and the non-fluent form of Primary Progressive Aphasia (PPA-NF, hesitant, non-fluent speech) may experience difficulties with prosody, fluency, and voice quality. Besides imaging and clinical-variables data, the researchers employed voice recording data to identify dementia using ML and DL algorithms. The data collection process for voice data varies from dataset to dataset, for example, in a few datasets, patients were requested to answer a prepared set of questions (interview) in a specific time interval. In a few datasets, selected neuropsychological tests were carried out, the description of each neuropsychological test was played and was followed by an answering window. Table 3 presents the dataset_id, dataset name, number of samples in the particular dataset, variables in the dataset, and finally the subtype of dementia.
Table 3
Summary of voice modality based datasets
Dataset_ID
Dataset
Samples
Variables
Dementia_Type
40
ADReSS
156
NA
AD
41
Aishell
120
NA
AD
42
TICS-J
123
36
Dementia
43
NA
16
192
Dementia
44
VBSD
36
254
AD
45
PAR
48
20
AD
46
ADReSS
156
NA
AD
47
NBD
09
03
Dementia
48
FHS
81
27
Dementia
49
Cheng Kung
98
8
AD
50
Aphasia
72
232
Dementia
51
EHC-Istanbul
51
30
AD
52
ADReSS
156
NA
AD
53
DementiaBank’s
1273
108
AD
54
NA
09
03
Dementia
55
Carolina Collection
21
3
AD
56
FHS
5449
NA
Dementia
57
PROMPT
120
82
Dementia
58
ADReSS
144
11
AD
59
DementiaBank’s
497
108
AD
60
AZTIAHO
70
NA
AD
61
Pitt Corpus
550
17
AD

Data sharing challenges

In this digital era, public health decision-making has grown progressively complicated, and the utilization of data has become critical [66]. Data are employed at the local level to observe public health and target interventions; at the national scale for resource allocation, prioritization, and planning; and at the global scale for disease burden estimates, progress in health and development measurement, and the containment of evolving global health threats [67, 68]. Van Panhuis et al. have adequately described the challenges to exchanging health data [69]. Based on our initial analysis, we built on this taxonomy to identify the hurdles related to data sharing in global public health, and we have highlighted how they may apply to each typology as given below.
1.
Lack of complete data, lost data, restrictive as well as conflicting data formats, a lack of metadata and standards, a lack of interoperability of datasets (e.g., structure or “language”), and a lack of appropriate analytic solutions are examples of technical barriers encountered by health information management systems.
 
2.
Individuals and organizations face motivational challenges when it comes to sharing data. These impediments include a lack of incentives, opportunity costs, apprehension about criticism, and disagreements over data usage and access.
 
3.
The potential and present costs of sharing data are both economic hurdles.
 
4.
Political obstacles are those that are built into the norms of local health governance and often emerge as regulations and guidelines. They can also entail trust and ownership difficulties.
 
5.
Legal issues that arise as a result of data collection, analysis, and usage include questions regarding who owns or controls the data, transparency, informed permission, security, privacy, copyright, human rights, damage, and stigma.
 
6.
Ethical constraints include a lack of perceived reciprocity (i.e., the other side will not disclose data) and proportionality (i.e., deciding not to share data based on an assessment of the risks and benefits). An overall concern is that frameworks, rules, and regulations have not kept up with technological changes that are transforming how data is collected, analyzed, shared, and used.
 

ML based diagnostic models for dementia: Image modality

In recent years, researchers have designed many ML and DL algorithms for the detection of dementia and its subtypes using MRI images of the brain. For example, Dashtipour et al. [70] proposed a ML based method for the prediction of Alzheimer’s disease. In their proposed model, they used DL techniques to extract the features from brain images, and for classification purposes, they deployed SVM and bidirectional long short-term memory (BiLSTM). Through their proposed model, they had reported the classification accuracy of 91.28%. Moreover, for early detection of the AD, a DL based approach was proposed by Helaly et al. In their proposed work, they employed convolutional neural networks (CNN). The Alzheimer’s disease spectrum is divided into four phases. Furthermore, different binary medical image classifications were used for each two-pair class of Alzheimer’s disease stages. Two approaches were used to categorize medical images and diagnose Alzheimer’s disease. The first technique employs basic CNN architectures based on 2D and 3D convolution to cope with 2D and 3D structural brain images from the ADNI dataset. They had achieved highly promising accuracies for 2D and 3D multi-class AD stage classification of 93.61% and 95.17%, respectively. The VGG19 pre-trained model had been fine-tuned and obtained an accuracy of 97% for multi-class AD stage classification [71]. Vandenberghe et al. had proposed a method for binary classification of 18F-flutemetramol PET using ML techniques for AD and mild cognitive impairment (MCI). They had tested whether support vector machines (SVM), a supervised ML technique, can duplicate the assignments made by blindfolded visual readers, as well as which image components had the highest diagnostic value according to SVM and how 18F-fluoromethylamol-based SVM classification compares to structural MRI-based SVM classification in the same cases. Their F-flutemetamol based classifier was able to replicate the assignments obtained by visual read with 100% accuracy [72]. Odusami et al. proposed a novel method for the detection of early-stage dementia from functional brain changes in MRI using a fine-tuned ResNet-18 network. Their research work presents a DL based technique for predicting MCI, early MCI, late MCI, and Alzheimer’s disease (AD). The ADNI fMRI dataset was used for analysis and consisted of 138 participants. On EMCI vs. AD, LMCI vs. AD, and MCI vs. AD, the fine-tuned ResNet18 network obtained classification accuracy of 99.99%, 99.95%, and 99.95%, respectively [73]. Zheng et al. had presented a ML based framework for differential diagnosis between VaD and AD using structural MRI features. The least absolute shrinkage and selection operator (LASSO) was then used to build a feature set that was fed into SVM for classification. To ensure unbiased evaluation of model performance, a comparative analysis of classification models was conducted using different ML algorithms to discover which one had better performance in the differential diagnosis between VaD and AD. The diagnostic performance of the classification models was evaluated using quantitative parameters derived from the receiver operating characteristic curve (ROC). The experimental finding had shown that the SVM with RBF performed well for the differential diagnosis of VaD and AD, with sensitivity (SEN), specificity (SPE), and accuracy (ACC) values of 82.65%, 87.17%, and 84.35%, respectively (AUC = 86.10–95%, CI = 0.820–0.902) [74]. Basheer et al. [75] had presented an innovative technique by making improvements in capsule network design for the best prediction outcomes. The study used the OASIS dataset with dimensions (373 X 15) to categorize the labels as demented or non-demented. To make the model swifter and more accurate, several optimization functions were performed on the variables, as well as the feature selection procedure. The claims were confirmed by demonstrating the correlation accuracy at various iterations and layers with an allowable accuracy of 92.39%. L. K. Leong and A. A. Abdullah had proposed a method for the prediction of AD based on ML techniques with the Boruta algorithm as a feature selection method. According to the Boruta algorithm, Random Forest Grid Search Cross Validation (RF GSCV) outperformed other 12 ML models, including conventional and fine-tuned models, with 94.39% accuracy, 88.24% sensitivity, 100.00% specificity, and 94.44% AUC even for the small OASIS-2 longitudinal MRI dataset [76]. Battineni et al. had presented a SVM based ML model for the prediction of dementia. Their proposed model had achieved an accuracy and precision of 68.75% and 64.18% using the OASIS-2 dataset [77]. Mathotaarachchi et al. had analyzed the amyloid imaging using ML approaches for the detection of dementia. To overcome the inherent unfavorable and imbalance proportions between persons with stable and progressing moderate cognitive impairment in a short observation period. The innovative method had achieved 84.00% accuracy and an AUC of 91.00% for the ROC [78]. Aruna and Chitra had presented a ML approach for the identification of dementia from MRI images, where they had deployed Independent Component Analysis (ICA) to extract the features from the images, and for classification purposes, SVM with different kernels is used. Through their proposed method, they had obtained an accuracy of 90.24% [79] (Fig. 5).
Supervised ML techniques and CNNs were examined by Herzog and Magoulas. They had achieved the accuracy of 92.5% and 75.0% for NC vs EMCI, 93.0% and 90.5% for NC vs. AD, respectively [80]. Battineni et al. had comprehensive applied ML model on MRI to predict Alzheimer’s disease (AD) in older subjects, and they had proposed two ML models for AD detection. In the first trial, manual feature selection was utilized for model training, and ANN produced the highest AUC of 81.20% by ROC. The NB had earned the greatest AUC of 94.20% by ROC in the second trial, which included wrapping approaches for the automated feature selection procedure [81]. Ma et al. had conducted a study where they compared feature-engineered and non-feature-engineered ML methods for blinded clinical evaluation for dementia of Alzheimer’s type classification using FDG-PET. The highest accuracy of 84.20% was obtained through CNN’s [82]. Bidani et al. had presented a novel approach in the field of DL that combines both the deep convolutional neural network (DCNN) model and the transfer learning model to detect and classify dementia. When the features were retrieved, the dementia detection and classification strategy from brain MRI images using the DCNN model provided an improved classification accuracy of 81.94%. The transfer learning model, on the other hand, had achieved an accuracy of 68.13% [83].
Moscoso et al. had designed a predictive model for the prediction of Alzheimer’s disease using MRI images. Their proposed model had obtained the highest accuracy of 84.00% [84]. Khan and Zubair had presented an improved multi-modal based ML approach for the prognosis of AD. Their proposed model had a five-stage ML pipeline, where each stage was further categorized into different sub-levels. Their proposed model had reported the highest accuracy of 86.84% using RF [85]. Mohammed et al. had evaluated the two CNN models (AlexNet and ResNet-50) and hybrid DL/ML approaches (AlexNet+SVM and ResNet-50+SVM) for AD diagnosis using the OASIS dataset. They had found that RF algorithm had attained an overall accuracy of 94%, as well as precision, recall, and F1 scores of 93%, 98%, and 96%, respectively [86]. Salvatore et al. had developed a ML method for early AD diagnosis using magnetic resonance imaging indicators. In their proposed ML model, they used PCA for extracting features from the images and SVM for the classification of dementia. They had achieved a classification accuracy of 76% using a 20-fold cross validation scheme [87]. Katako et al. had identified the AD related FDGPET pattern that is also found in LBD and Parkinson’s disease dementia using ML approaches. They studied different ML algorithms, but SVM with an iterative single data algorithm produced the best performance, i.e., sensitivity 84.00%, specificity 95.00% through 10-fold cross-validation [88]. Gray et al. had presented a system in which RF proximities were utilized to learn a low-dimensional manifold from labelled training data and then infer the clinical labels of test data that translated to this space. Their proposed model, voxel-based (FDG-PET), obtained an accuracy of 87.9% using ten-fold cross-validation [89]. Table 4 provides the overall performance evaluation of the ML models that were presented by the researchers for the prediction of dementia and its subtypes by using image data as a modality.
Table 4
Performance evaluation of image-modality based ML models for dementia
S.No
Authors
Year
D_ID\(^{*}\)
Feature
Model
Metrics
Acc.%
Spec.%
Sens.%
1
Dashtipour et al. [70]
2021
01
CNN
BiLSTM
k-fold
93.19
93.00
93.00
2
Helaly et al. [71]
2021
02
CNN
BMIC
MCC
97.00
98.00
94.00
3
Vandenberghe et al. [72]
2012
03
Voxels
SVM
MCC
100
92.00
85.00
4
Odusami et al. [73]
2021
04
ReLU
CNN
MCC
98.74
100
97.24
5
Zheng et al. [74]
2019
05
LASSO
SVM
ROC
87.17
87.17
82.65
6
Basheer et al. [75]
2019
06
KPCA
CNN
MCC
92.30
NA
NA
7
Leong et al. [76]
2019
07
Boruta
RF
MCC
94.39
100
84.24
8
Battineni et al. [77]
2019
08
RBF
SVM
MCC
68.75
NA
NA
9
Mathotaarachchi et al. [78]
2017
9
\(\chi ^{2}\)
RUSRF
F1-score
90.60
86.50
70.80
10
Aruna and Chitra [79]
2015
10
ICA
SVM
MCC
90.24
NA
NA
11
Herzog et al. [80]
2021
11
std, RMS
CNN
MCC
90.50
90.00
93.00
12
Battineni et al. [81]
2020
12
ANN
NB
ROC
94.20
89.56
89.92
13
Ma et al. [82]
2021
13
FPDS
CNN
MCC
89.30
67.00
84.50
14
Bidani et al. [83]
2019
14
K-means
DNN
MCC
81.94
NA
NA
15
Moscoso et al. [84]
2019
15
NA
ML
AUC
84.00
71.00
78.00
16
De Bruijne [90]
2016
16
DNN
SVM
ROC
65.00
88.00
80.00
17
Mohammed et al. [86]
2020
16
IFS
ML
ROC
90.00
93.00
98.00
18
Salvatore et al. [87]
2015
13
PCA
SVM
k-fold
76.00
NA
NA
19
Katako et al. [88]
2018
09
ISDA
SVM
AUC
94.50
95.00
84.00
20
Moscoso et al. [89]
2019
16
FSL FAST
RF
MCC
76.00
89.80
88.90
21
Tong et al. [91]
2014
11
mi-Graph
SVM
k-Fold
89.00
92.60
84.90
22
Akhila et al. [92]
2017
10
SFTA
ANN
MCC
97.50
97.50
97.50
23
Chen and Pham [93]
2013
16
mi-Graph
Markov
k-Fold
78.30
76.00
79.00
24
Patil and Yardi [94]
2013
NA
DCT
ANN
MCC
100
NA
NA
25
Gulhare et al. [95]
2017
06
niblack
DNN
MCC
96.60
NA
NA
D_ID\(^*\): is a reference number of Dataset ID

ML based diagnostic models for dementia: Clinical-variable modality

Aside from image-based ML techniques for dementia prediction, several research studies have utilized clinical-variable data with ML algorithms to predict dementia and its subtypes. For instance, Chiu et al. had designed a screening instrument to detect MCI and dementia using ML techniques. They had developed a questionnaire to assist neurologists and neuropsychologists in the screening of MCI and dementia. The contribution of 45 items that matched the patient’s replies to questions was ranked using feature selection through information gain (IG). Among the 45 items, 12 were ranked the highest in feature selection. The ROC analysis showed that AUC in test group was 94.00% [96]. Stamate et al. had developed a framework for the prediction of MCI and dementia. Their proposed framework was based on the ReliefF approach paired with statistical permutation tests for feature selection, model training, tweaking, and testing using ML algorithms such as RF, SVM, Gaussian Processes, Stochastic Gradient Boosting, and eXtreme Gradient Boosting. The stability of model performances was studied using computationally expensive Monte Carlo simulations, and the results of their proposed framework were given as for dementia detection, the accuracy was 88.00%, sensitivity was 93.00%, and the specificity was 94.00%, whereas moderate cognitive impairment had a sensitivity of 86.00% and a specificity of 90% [97]. Stamate et al. developed a system for detecting dementia subtypes (AD) in blood utilizing DL and other supervised ML approaches such as RF and extreme gradient boosting. The AUC for the proposed DL method was 85% (0.80–0.89), for XGBoost it was 88% (0.86–0.89), and for RF it was 85% (0.83–0.87). In comparison, CSF measurements of amyloid, p-tau, and t-tau (together with age and gender) gave AUC values of 78%, 83%, and 87%, respectively, by using the XGBoost [98]. Bansal1 et al. had performed the comparative analysis of the different ML methods for the detection of dementia using clinical-variables. In their experiments, they exploited the performance of four ML models, such as J48, NB, RF, and multilayer perceptrons. From the results of experiments, they had concluded that j48 outperformed the rest of the ML models for the detection of dementia [99]. Nori et al. had experimented the lasso algorithm on a big dataset of patient and identify the 50 variables by ML model with an AUC of 69.30% [100]. Alam et al. [101]used signal processing on wearable sensor data streams (e.g., electrodermal activity (EDA), photoplethysmogram (PPG), and accelerometer (ACC)) and machine learning techniques to measure cognitive deficits and their relationship with functional health deterioration.
Gurevich et al. had used SVM and neuropsychological test for the classification of AD from other causes of cognitive impairment. The highest classification accuracy they had achieved through their proposed method was 89.00% [102]. Karaglani et al. had proposed a ML based automated diagnosis system for AD by using blood-based biosignatures. In their proposed method, they used mRNA-based statistically equivalent signatures for feature ranking and a RF model for classification. Their proposed automated diagnosis system had reported the accuracy of 84.60% using RF [103]. Ryzhikova et al. had analyzed cerebrospinal fluid for the diagnosis of AD by using ML algorithms. For classification purposes, artificial neural networks (ANN) and SVM discriminant analysis (SVM-DA) statistical methods were applied, with the best findings allowing for the distinguishing of AD and HC participants with 84.00% sensitivity and specificity. The proposed classification models have a high discriminative power, implying that the technique has a lot of potential for AD diagnosis [104]. Cho and Chen had designed a double layer dementia diagnosis system based on ML where fuzzy cognitive maps (FCMs) and probability neural networks (PNNs) were used to provide initial diagnoses at the base layer, and Bayesian networks (BNs) were used to provide final diagnoses at the top layer. Diagnosis results, “proposed treatment,” and “no treatment required” might be used to provide medical institutions with self-testing or secondary dementia diagnosis. The highest accuracy reported by their proposed system was 83.00% [105]. Facal et al. had studied the role of cognitive reserve in the conversion from MCI to dementia using ML. Nine ML classification algorithms were tried in their study, and seven relevant performance parameters were generated to assess the prediction accuracy for converted and non-converted individuals. The use of ML algorithms on socio-demographic, basic health, and CR proxy data allowed for the prediction of dementia conversion. The Gradient Boosting Classifier (ACC = 0.93; F1 = 0.86 and Cohen’s kappa = 0.82) and RF Classifier (ACC = 92%; F1 = 0.79 and Cohen’s kappa = 0.71) performed the best [106]. Jin et al. had proposed automatic classification of dementia from learning of clinical consensus diagnosis in India using ML techniques. All viable ML models exhibited remarkable discriminative skills (AUC >90%) as well as comparable accuracy and specificity (both around 95%). The SVM model beat other ML models by obtaining the highest sensitivity (0.81), F1 score (0.72), kappa (.70, showing strong agreement), and accuracy (second highest) (0.65). As a consequence, the SVM was chosen as the best model in their research work [107]. James et al. had evaluated the performance of ML algorithms for predicting the progression of dementia in memory clinic patients. According to their findings, ML algorithms outperformed humans in predicting incident all-cause dementia within two years. Using all 258 variables, the gradient-boosted trees approach had an overall accuracy of 92% , sensitivity of 0.45, specificity of 0.97, and an AUC of 0.92. Analysis of variable significance had indicated that just 6 variables were necessary for ML algorithms to attain an accuracy of 91% and an AUC of at least 89.00% [108]. Bougea et al. had investigated the effectiveness of logistic regression (LR), K-nearest neighbours (K-NNs), SVM, the Naive Bayes classifier, and the Ensemble Model to correctly predict PDD or DLB. The K-NN classification model exhibited an overall accuracy of 91.2% based on 15 top clinical and cognitive scores, with 96.42% sensitivity and 81% specificity in distinguishing between DLB and PDD. Based on the 15 best characteristics, the binomial logistic regression classification model had attained an accuracy of 87.5%, with 93.93% sensitivity and 87% specificity. Based on the 15 best characteristics, the SVM classification model had achieved an accuracy of 84.6% of overall instances, 90.62% sensitivity, and 78.58% specificity. A model based on NB classification obtained an accuracy of 82.05%, sensitivity of 93.10%, and a specificity of 74.41%. Finally, an ensemble model, which was constructed by combining the separate ones, attained 89.74% accuracy, 93.75% sensitivity, and 85.73% specificity [109] (Fig. 6).
Salem et al. had presented a regression-based ML model for the prediction of dementia. In their proposed method, they had investigated ML approaches for unbalanced learning. In their suggested supervised ML approach, they started by intentionally oversampling the minority class and undersampling the majority class, in order to reduce the bias of the ML model to be trained on the dataset. Furthermore, they had deployed cost-sensitive strategies to penalize the ML models when an instance was misclassified in the minority class. According to their findings, the balanced RF was the most resilient probabilistic model (with just 20 features/variables) with an F1 score of 0.82, a G-Mean of 0.88, and an AUC of 0.88 using ROC. With a F1-score of 0.74 and an AUC of 0.80 by ROC, the calibrated-weighted SVM was their top classification model for the same number of features [110]. Gutierrez et al. had designed an automated diagnosis system for the detection of AD and FTD by using feature engineering and genetic algorithms. Their proposed system had obtained the accuracy of 84% [111]. Mirzaei and Adeli had analyzed the state-of-the-art ML techniques used for the detection and classification of AD [112]. Hsiu et al. had studied ML algorithms for early identification of cognitive impairment. Their proposed model had obtained the accuracy of 70.32% by threefold cross-validation scheme [113]. Several classification models were constructed using various ML and feature selection methodologies to automate MCI detection using gait biomarkers. They had demonstrated, however, that dual-task walking differentiated between MCI and CN individuals. The ML model used for MCI pre-screening based on inertial sensor-derived gait biomarkers achieved 71.67% accuracy and 83.33% sensitivity, respectively, as reported by Shahzad et al. [114]. Hane et al. investigated the use of deidentified clinical notes acquired from multiple hospital systems over a 10-year period to enhance retrospective ML models predicting the risk of developing AD. The AUC improved from 85.00% to 94.00% by utilizing clinical notes, and the positive predictive value (PPV) rose from 45.07% (25,245/56,018) to 68.32% (14,153/20,717) in the model at the beginning of disease [115]. Table 5 provides the overall performance evaluation of the ML models that were presented by the researchers for the prediction of dementia and its subtypes by using clinical-variable data as a modality.
Table 5
Performance evaluation of Clinical-Variable based ML models for dementia
S.No
Authors
Year
D_ID\(^{*}\)
Feature
Model
Metrics
Acc.%
Spec.%
Sens.%
1
Chiu et al. [96]
2019
17
IG
DT
ROC
96.00
93.00
92.00
2
Stamate et al. [97]
2018
18
SVM
RF
k-fold
88.00
94.00
93.00
3
Visser et al. [98]
2019
19
XGBoost
RF
k-fold
85.00
NA
NA
4
Bansal et al. [99]
2018
20
WEKA
J48
k-fold
98.66
95.00
81.00
5
Nori et al. [100]
2019
21
Lasso
RF
AUC
69.30
98.70
16.40
6
Alam et al. [101]
2016
22
high-pass filter
RF
k-fold
91.50
91.80
95.70
7
Gurevich et al. [102]
2017
23
PCA
SVC
MCC
89.00
94.00
74.00
8
Karaglani et al. [103]
2020
24
mRNA
RF
ROC
84.60
NA
NA
9
Ryzhikova et al. [104]
2021
25
GA
SVM-DA
k-fold
90.30
84.00
84.00
10
Cho and Chen [105]
2012
26
FCM
PNNs
NA
82.00
NA
NA
11
Facal et al. [106]
2019
27
ANN
RF
k-fold
92.00
88.00
88.00
12
Jin et al. [107]
2021
28
NA
SVM
MCC
96.00
95.00
81.00
13
James et al. [108]
2021
29
NA
GBT
k-fold
92.00
97.00
45.00
14
Bougea et al. [109]
2021
30
NA
K-NN
AUC
91.00
85.73
93.75
15
Salem et al. [110]
2021
31
NA
RF
ROC
88.00
NA
NA
16
Garcia-Gutierrez et al. [111]
2022
32
GA
DT
F1-score
88.00
NA
NA
17
Mirzaei and Adeli [112]
2022
33
RF
CNN
k-fold
95.74
NA
NA
18
Hsiu et al. [113]
2022
34
LDA
KNN
k-fold
70.32
72.00
68.00
19
Shahzad et al. [114]
2022
35
EFA
SVM
k-fold
71.67
NA
83.33
20
Hane et al. [115]
2020
36
NA
ML
AUC
94.00
98.00
45.00
21
Aschwanden et al. [116]
2020
37
NA
RF
AUC
64.00
NA
67.00
22
Ryu et al. [117]
2020
20
HPO
XGBoost
K-fold
85.61
81.40
77.27
23
de Langavant et al. [118]
2018
37
PCA
k-mean
AUC
91.00
93.30
93.60
24
Fouladvand et al. [119]
2019
38
RNN
RF
F1-score
82.00
44.30
13.00
25
Balea-Fernandez et al. [120]
2021
39
GA
RF
AUC
80.00
71.00
100
D_ID\(^*\): is a reference number of Dataset ID

ML based diagnostic models for dementia: Voice modality

Similar to the image and clinical-variable modalities, researchers had also developed automated diagnostic systems based on voice data for the prediction of dementia. Hereby, we have reviewed the research work done by the scientists in detail. For example, Chlasta and Wolk had worked on the computer-based automated screening of dementia patients by spontaneous speech analysis using DL and ML techniques. In their work, they used neural networks to extract the features from the voice data; the extracted features were then fed into a linear SVM for classification purposes. Their SVM model had obtained the accuracy of 59.1% while CNN based ML model had reported the accuracy of 63.6% [121]. Chien et al. had presented an ML model for the assessment of AD using speech data. Their suggested model included a feature sequence that was used to extract the features from the raw audio data, as well as a recurrent neural network (RNN) for classification. Their proposed ML model had reported an accuracy of 83.80% based on the ROC curve [122]. Shimoda et al. had designed an ML model that identified the risk of dementia based on the voice feature in telephone conversations. Extreme gradient boosting (XGBoost), RF, and LR based ML models were used, with each audio file serving as one observation. The predictive performance of the constructed ML models was tested by characterizing the ROC curve and determining the AUC, sensitivity, and specificity [123]. Nishikawa et al. had developed an ensemble discriminating system based on a classifier with statistical acoustic characteristics and a neural network of transformer models, with an F1-score of 90.70% [124]. Liu et al. had introduced a new technique for recognizing Alzheimer’s disease that used spectrogram features derived from speech data, which aided families in comprehending the illness development of patients at an earlier stage, allowing them to take preventive measures. They used ML techniques to diagnose AD using speech data collected from older adults who displayed the attributes described in the speech. Their proposed method had obtained the maximum accuracy of 84.40% based on LogisticRegressionCV [125]. Searle et al. had created a ML model to assess spontaneous speech, which might potentially give an efficient diagnostic tool for earlier AD detection. Their suggested model was a fundamental Term Frequency-Inverse Document Frequency (TF-IDF) vectorizer as input into an SVM model, and the top performing models were a pre-trained transformer-based model ’DistilBERT’ when used as an embedding layer into simple linear models. The proposed model had obtained the highest accuracy of 82.00% [126]. Zhu et al. had suggested an ML model that employed the speech pause as an effective biomarker in dementia detection, with the purpose of reducing the detection, model’s confidence levels by adding perturbation to the speech pauses of the testing samples. They next investigated the impact of the perturbation in training data on the detection model using an adversarial training technique. The proposed model had achieved an accuracy of 84.00% [127]. Ossewaarde et al. had proposed ML model based on SVM for the classification of spontaneous speech of individuals with dementia based on automatic prosody analysis. Their findings suggest that the classifier can distinguish some dementia types (PPA-NF, AD), but not others (PD) [128]. Xue et al. had developed an ML model based on DL for the detection of dementia by using voice recordings. In their ML model, long short-term memory (LSTM) network and the convolutional neural network (CNN) utilized audio recordings to categorize whether the recording contained a participant with either NC or only DE and to discriminate between recordings belonging to those with DE and those without DE (i.e., NDE (NC+MCI)) [129]. Weiner et al. had presented two pipelines of feature extraction for dementia detection: the manual pipeline used manual transcriptions, while the fully automatic pipeline used transcriptions created by automatic speech recognition (ASR). The acoustic and linguistic features that they had extracted need no language specific tools other than the ASR system. Using these two different feature extraction pipelines, they had automatically detect dementia [130] (Fig. 7).
Furthermore, Sadeghian et al. had presented the empirical evidence that a combination of acoustic features from speech, linguistic features were extracted from an automatically determined transcription of the speech including punctuation, and results of a mini mental state exam (MMSE) had achieved strong discrimination between subjects with a probable AD versus matched normal controls [131]. Khodabakhsh et al. had evaluated the linguistic and prosodic characteristics in Turkish conversational language for the identification of AD. Their research suggested that prosodic characteristics outperformed linguistic features by a wide margin. Three of the prosodic features had helped to achieve a classification accuracy of more than 80%, However, their feature fusion experiments did not improve classification performance any more [132]. Edwards et al. had analyzed the text data at both the word level and phoneme level, which leads to the best-performing system in combination with audio features. Thus, the proposed system was both multi-modal (audio and text) and multi-scale (word and phoneme levels). Experiments with larger neural language models had not resulted in improvement, given the small amount of text data available [133]. Kumar et al. had identified speech features relevant in predicting AD based on ML. They had deployed neural network for the classification and obtained the accuracy of 92.05% [134]. Ossewaarde et al. had built ML model based on SVM for the classification from spontaneous speech of individuals with dementia by using automatic prosody [128]. Luz et al. had developed an ML approach for analyzing patient speech in dialogue for dementia identification. They had designed a prediction model, and the suggested strategy leveraged additive logistic regression (ML boosting method) on content-free data gathered through dialogical interaction. Their proposed model obtained the accuracy of 86.50% [135]. Sysed et al. had designed a multimodal system that identified linguistic and paralinguistic traits of dementia using an automated screening tool. Their proposed system had used bag-of-deep-feature for feature selection and ensemble model for classification [136]. Moreover, Sarawgi et al. had used multimodal inductive transfer learning for AD detection and severity. Their proposed system further achieved state-of-the-art AD classification accuracy of 88.0% when evaluated on the full benchmark DementiaBank Pitt database. Table 6 provides the overall performance evaluation of the ML models that were presented by the researchers for the prediction of dementia and its subtypes by using voice-modality data.
Table 6
Performance evaluation of voice-modality based ML models for dementia
S.No
Authors
Year
D_ID\(^{*}\)
Feature
Model
Metrics
Acc.%
Spec.%
Sens.%
1
Chlasta and Wołk [121]
2021
40
VGGish
CNN
F1-score
63.60
NA
NA
2
Chien et al. [122]
2021
41
CRNN
RNN
ROC
83.80
83.80
75.60
3
Shimoda et al. [123]
2021
42
PRAAT
RF
AUC
88.20
80.00
96.40
4
Nishikawa et al. [124]
2022
43
lightGBM
ViT_b16
F1-score
90.70
NA
87.5
5
Liu et al. [125]
2019
44
Spectrogram
LR
k-fold
84.40
91.30
87.50
6
Searle et al. [126]
2022
45
CRF
SVM
F1-score
82.00
NA
NA
7
Zhu et al. [127]
2021
46
Wav2vec
BERT
ROC
83.00
NA
NA
8
Ossewaarde et al. [128]
2019
47
VAD
SVM
ROC
93.00
NA
NA
9
Xue et al. [129]
2021
48
RNN
CNN
AUC
80.50
75.00
87.30
10
Weiner [130]
2017
49
ASR
DNN
Acc
90.24
NA
NA
11
Sadeghian et al. [131]
2017
50
VAD
NN
Acc
91.70
NA
NA
12
Khodabakhsh et al. [132]
2015
51
VAD
NN
Acc
80.00
NA
NA
13
Edwards et al. [133]
2020
52
LDA
RF
F1-score
92.30
NA
NA
14
Kumar et al. [134]
2021
53
SVC
NN
MCC
92.05
NA
NA
15
Ossewaarde et al. [128]
2019
54
VAD
SVM
ROC
84.00
NA
NA
16
Luz et al. [135]
2018
55
VGO
SVM
ROC
86.50
88.00
81.20
17
Xue et al. [129]
2021
56
LSTM
CNN
AUC
80.50
NA
NA
18
Orsulic-Jeras et al. [137]
2021
57
PCA
SVM
k-fold
76.00
NA
NA
19
Syed et al. [136]
2021
58
Fusion
SVC
Acc
95.37
94.44
96.30
20
Sarawgi et al. [138]
2020
59
PCA
Ensemble
F1-score
88.00
NA
NA
21
Calza et al. [139]
2021
NA
SSVAD v1.0
RF
F1-score
75.00
NA
NA
22
Haider et al. [140]
2019
60
eGeMAPS
LDA
F1-score
78.70
NA
NA
23
López-de-Ipiña et al. [141]
2015
61
SSF + EF
SVM
k-fold
86.04
NA
NA
24
Orimaye et al. [142]
2014
60
IG
SVM
F1-score
74.00
75.00
73.00
25
Santander-Cruz et al. [143]
2022
61
BERT
SVM
k-fold
77.00
80.00
80.00
D_ID\(^*\): is a reference number of Dataset ID

Discussion

In this SLR, we examined the research work that employed ML and DL algorithms to analyze clinical data in order to identify variables that might help predict dementia. We studied 75 research articles that were published in the last 10 years that used image, clinical-variable, and voice data to predict dementia and its subtypes. Nowadays, the healthcare industry creates a vast quantity of data on patients’ health; this data is used by researchers to enhance individual health by utilizing developing technologies such as ML and DL. As a result, researchers can not only distinguish dementia patients from healthy people with high accuracy, but also forecast the disease progression of MCI patients.
Therefore, researchers have expressed a strong interest in designing and developing automated diagnostic systems based on ML and DL techniques. As seen in Fig. 4., there has been an exponential increase in the number of such research publications that use ML algorithms for dementia prediction and detection in the previous four years. We investigated the selected papers using significant performance assessment criteria for ML and DL approaches such as data attributes, computational methodologies, and study emphasis. In this SLR, we have uncovered research gaps in the present literature as well as anticipated future research opportunities. Additionally, in Fig. 8 model comparison, we examined the performance of multiple ML algorithms for dementia prediction based on three types of data modalities: image, clinical-variable, and voice. The accuracy gained by image-based ML algorithms is higher when compared to clinical-variable and voice modalities, as shown in Fig. 8 model comparison. Moreover, the researchers’ suggested SVM, RF, and ANN-based ML techniques outperformed the rest of the ML algorithms in terms of performance. According to Fig. 8 model comparison, voice modality-based ML models show worse accuracy when compared to image and clinical-variable modality data. As a result, there is still a performance gap for researchers to close in order to improve the performance of ML algorithms for the prediction of dementia using voice data. Hence, researchers have shown a strong interest in the creation of automated diagnosis systems for dementia prediction utilizing speech data and ML algorithms, as illustrated in Fig. 4.
The ML and DL models are likely prone to problems such as poor quality of data, poor selection of ML model, Bias Variance tradeoff and training too complex models. Thus, scientists have developed various evaluation metrics (i.e., ROC, AUC, MCC, F1-score, K-fold) and methods to avoid these problems. The data is a crucial element in ML because ML models work only with numeric data; therefore, poor data quality results in lower performance of ML models. Moreover, imbalance classes in the dataset also cause the bias results from the ML models. Thus, this problem can be overcome by oversampling or undersampling the training data. There are different techniques that are used by the AI engineers for oversampling, such as random oversampling and the synthetic minority oversampling technique (SMOTE). To evaluate the bias researchers’ work, use sensitivity and specificity as an evaluation metric to measure the bias of the ML model. Higher values of sensitivity and specificity means model is free from the biasness while having either one parameter value higher and other one is lower means there is biasness exist. Thus, we have also studied the sensitivity and specificity, along with the accuracy, of the previously proposed ML models for dementia prediction. Figure 9 Comparison provides a brief description of the sensitivity and specificity of the ML models for the detection of dementia based on different data modalities. From Fig. 9, we can observe that ML models have higher values for sensitivity and specificity when using image data as compared to clinical-variable and voice modality data. In comparison to accuracy from Fig. 8 to sensitivity and specificity from Fig. 9, we have noted that the results obtained from image based modality are more reliable and precise using ML and DL algorithms in spite of clinical and voice modality.
Furthermore, the correlation between sensitivity and specificity would help us understand the efficacy of the ML models, which are designed for automated disease prediction. The mathematical terms “sensitivity” and “specificity” indicate the accuracy of a test that reports the presence or absence of a disease. Individuals who meet the requirement are labelled “positive,” while those who do not are considered “negative”. The chance of a positive test, conditioned on being actually positive, is referred to as sensitivity (the true positive rate), while specificity (true negative rate) is the likelihood of a negative test if it is actually negative. Sensitivity and specificity are inversely proportional, which means that as sensitivity rises, specificity falls, and vice versa. Mathematically, sensitivity and specificity are given as:
$$\begin{aligned} Sensitivity = \frac{TP }{TP + FN} \end{aligned}$$
(1)
$$\begin{aligned} Specificity = \frac{TN }{TN+ FP} \end{aligned}$$
(2)
On the other hand, accuracy is a ratio of number of correct assessments / number of all assessments. The proportion of genuine positive outcomes (both true positive and true negative) in the selected population is represented by the numerical value of accuracy. The test result is accurate 99% of the time, whether positive or negative. For the most part, this is right. However, it is worth noting that the equation of accuracy means that even if both sensitivity and specificity are high, say 99%, this does not imply that the test’s accuracy is also high. In addition to sensitivity and specificity, accuracy is determined by the prevalence of the illness in the target population. A diagnosis for a rare ailment in the target group may have high sensitivity and specificity but low accuracy. However, for a balanced dataset, ML models with higher sensitivity and specificity result in higher accuracy. Hence, accuracy must be interpreted carefully. The mathematical formula for accuracy is given as:
$$\begin{aligned} Accuracy = \frac{TP + TN}{TP + TN + FP+FN} \end{aligned}$$
(3)
where, TP stands for the number of true positives, FP stands for the number of false positives, TN stands for the true negative, and FN stands for the false negative.
We classified all datasets that were used by researchers to test the performance of their proposed ML models for the prediction of dementia (AD, VaD, MCI, and FTD) into three types: image, clinical-variable, and voice. A total of 61 datasets were examined in terms of the number of samples and variables in the datasets. In image modality datasets from the Table 1, it can be observed that the ADNI dataset has a significant number of samples, which is 750, while the NINDS-AIREN dataset has more variables as compared to the rest of the datasets in the image modality data. Moreover, from the Table 2 of clinical-variable modality datasets, it can be noticed that the ADRD dataset has the highest number of samples (44945) as compared to the rest of the dataset, while the Raman spectral dataset has the highest number of variables (366). In the last, Table 3 of voice data modality elaborated the dataset of voice modality where FHS dataset has highest number of samples of 5449 while VBSD dataset had highest variables of 254 as compared to rest of the datasets in voice modality. The type of data and the size of the dataset are two important factors that have a significant influence on the performance of ML models. Thus, we have also studied this factor by comparing the accuracy along with the number of samples in the dataset with respect to data modalities. From Fig. 10, it can be observed that the majority of the ML models that used image data have higher accuracy along with a higher number of samples in the dataset. There are few ML models that show poor performance when the number of samples in the dataset is large. While, clinical-variable and voice modalities show prominent performance when the number of samples in the dataset is small.
Moreover, we examined the effectiveness of ML classifiers utilized by the researchers in their proposed automated diagnostic systems for dementia prediction and classification. According to the selected studies of this SLR, SVM is the most commonly used ML classifier by researchers for the classification of patients and normal subjects using three data modalities (i.e., image, clinical-variable, voice), RF is the second most commonly used ML classifier by researchers, and CNN is the third most commonly used ML classifier by researchers. It can be observed from the Fig. 11. SVMs are the most powerful tools for the binary classification task, along with RF. From Fig. 8, we can see that SVM also obtained the highest average accuracy based on three types of data modalities. Hence, this factor also encourages the scientists to employ SVM as a binary classifier for dementia prediction or other disease prediction systems. From Fig. 11, we can observe the percentage of other ML classifiers that were used by the researchers in selected research articles for the automated diagnosis of dementia.
There are several evaluation metrics that are used for the performance assessment of ML models, such as F1score, AUC, ROC, Matthew’s correlation coefficient (MCC), cross-validation, K-fold, specificity, sensitivity, and accuracy. Each evaluation metric has its own pros and cons. Thus, the selection of appropriate evaluation metrics for the assessment of the ML model is essential to understanding its efficiency and performance. For instance, when data plays a vital role in ML models for decision-making and a dataset has unbalanced classes, it may be possible that results from the ML predictive model might be biassed due to the unbalanced nature of the data in the dataset. Thus, here evaluation metrics help to eliminate the factor of biasness in the results, i.e., the k-fold. The F1-score evolution metric is suitable for the classification of multiple classes in the dataset. while ROC tells us how well the ML model can differentiate binary classes. As a result, AUC and ROC reveal how effectively the probabilities from the positive classes are separated from the probabilities from the negative classes. From Fig. 12, it can be depicted that cross validation is mostly used in the studies that were selected for this SLR to evaluate the performance of proposed ML models. MCC is the second most used evaluation metric, while ROC is in third place. The proposition of other evaluation metrics used by the researchers to validate the efficiency of their proposed ML models can be observed from Fig. 12.

Limitations in the previously proposed ML models

ML algorithms have been effectively applied to a broad range of real-world challenges, including banking, cybersecurity, transportation, and robots. They do, however, have fundamental limitations that make them inappropriate for every problem. In the clinical domain, researchers have concentrated on the supervised learning approach, developing various automated diagnostics for AD, MCI, and dementia prediction using supervised machine algorithms. From the Figs. 8 and 11, It can be noticed that supervised ML classifiers are mostly used by the researchers in the selected past research articles. Because supervised machine learning approaches have various limitations, automated diagnostic methods for dementia prediction based on supervised techniques suffer from some, if not all, of these constraints. In this part, we have examined the drawbacks of supervised ML-based techniques for dementia prediction, which are as follows:
1.
The model overfitting problem affects the performance of ML models. As previously indicated, several researchers have used the k-fold cross-validation approach to evaluate the efficacy of their constructed diagnostic system. However, because of data leaks, it may result in highly biassed findings.
 
2.
To deal with problem of imbalance classes in the dataset, Researchers and scientists had devised several techniques to eliminate the problem of imbalance classes such as random oversampling example (ROSE), synthetic minority over-sampling technique (SMOTE) and random over sampling (ROS) etc. Unfortunately, in the selected study, the researchers had not considered this factor to deal with the problem of imbalanced classes in the dataset that cause problems of bias.
 
3.
Supervised ML models require training on a dataset; nevertheless, training on a large quantity of significant data is a hard and time-consuming job, especially for slow learning algorithms like kNN.
 
4.
For training and testing of the ML models, researchers had used different data partitioning methods, which resulted in inconsistent comparisons of accuracy and other evaluation metrics among the proposed ML models for dementia prediction. Thus, standard data partition schemes should be adopted (holdout) for the comparison of ML models developed by the researcher for dementia prediction.
 
5.
Another challenge with ML-based automated diagnostic systems for dementia is the time complexity of the proposed ML algorithms. The time complexity means the overall time require to complete all the computational tasks by the ML model for making a prediction. The ML model can forecast results only after it has been trained on the training data, which takes time to analyze. Furthermore, ML models include a large number of parameters that must be manually modified in the case of supervised learning. As a result, it takes a significant amount of effort and time to fine-tune the hyperparameters of the ML model in order to get higher performance.
 
6.
DL technology has demonstrated cutting-edge performances for the prediction of various diseases in the recent years. However, DL technology needs a massive quantity of data for model training, which is a time-consuming and tough task. Due to the complexity of data models, training is quite costly. Furthermore, DL necessitates the use of pricey GPUs and hundreds of workstations, which are not effective in terms of economics.
 

Future research directions

In recent years, several ML models have been presented for the prediction of AD and MCI; nevertheless, there are still certain areas that need to be explored by academics and experts. In this section, we have discussed different research areas and the future prospects of ML algorithms for dementia detection. We infer from this study that the following major parameters have a role in the efficient identification of dementia and its forms.
Data is extremely important in the case of ML-based automated detection of dementia, especially when DL models are considered. Many of the publicly available datasets, however, are modest in size. But future research should concentrate on gathering a huge number of samples for the datasets. In this SLR, we studied ML-based automated diagnostic systems for dementia prediction using three different kinds of data modalities (image, clinical_variable, voice). From Fig. 10, it can be observed that only the image modality based ML model obtained the higher accuracy along with the large size of the dataset, while the voice modality based ML model obtained the higher accuracy on a small dataset. Thus, for the researchers, there is still room available for designing and developing the automated prediction of dementia and its sub-types by using voice data. Therefore, the interest of researchers have been tremendously raised for the development of automated diagnostic systems for dementia prediction using voice data modality and this trend can be confirmed from the Fig. 4. There is still a lot room available for the improvement in design and construction of automated diagnostic systems for the dementia using clinical-variable data modality for the researchers. Because, the ML model was developed in the past using clinical-variable data, it displays mix performance by using clinical_variable modality, i.e., when the number of samples is lower in the dataset, the ML shows lower accuracy. Thus. In the future, we need to increase the number of samples in the dataset so that we have larger datasets for experimental purposes and the designed ML model can be effectively evaluated.
In selected studies of this SLR, the majority of ML algorithms belong to the supervised category of learning. While few researchers used an unsupervised ML approach for the prediction of dementia and its subtypes, Altough, unspervsied learning approaches suffer from the limitation such as less accuracy, more expensive in term of computational etc. Therefore, it will encourage scientists and researchers to design and construct new techniques and methods using supervised ML algorithms that are more precise and accurate for the prediction of dementia and its subtypes. Moreover, in this SLR, we have analysed the various ML models based on three data modalities (image, clinical-variable, and voice), and we have comprehensively compared previously proposed ML-based systems in terms of various evaluation metrics, but with different data modalities, it would be suggested that multimodal processing techniques based on ML would provide more reliable and efficient results. Hence, in the future, researchers should exploit multimodal approaches based on ML for a better prediction of dementia and its subtypes.

Conclusion

In contrast to earlier SLR studies that examined numerous ML techniques proposed for the automated diagnosis of dementia and its subtypes (AD, VaD, FTD, and MCI) using one type of data modality, this study reviewed ML methods for dementia considering different types of data modalities such as image data, clinical variables, and voice data. The research articles published from 2011 to 2022 were gathered using different databases. It was pointed out that ML approaches based on image data modality has shown better performance compared with ML methods trained on clinical variables based data and voice data modality. Furthermore, this study critically evaluated the previously proposed methods and highlighted limitations in these methods. To overcome these limitations, this study presented future research directions in the domain of automated dementia prediction using ML approaches. We hope that this SLR will be helpful for AI and ML researchers and medical practitioners who are working in the domain of automated diagnostic systems for dementia prediction.

Acknowledgements

The first author’s learning process was supported by the National E-Infrastructure for Aging Research (NEAR), Sweden. NEAR is working on improving the health condition of older adults in Sweden.

Declarations

Ethics Approval

This study was carried out in accordance with the Declaration of Helsinki and was approved by the Research Ethics Committee at Blekinge Institute of Technology (BTH).
Not applicable.
Not applicable.

Conflict of Interest

The authors declare no conflict of interest.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Menéndez, G.: La revolución de la longevidad: cambio tecnológico, envejecimiento poblacional y transformación cultural. Revista de Ciencias Sociales 30(41), 159–178 (2017) Menéndez, G.: La revolución de la longevidad: cambio tecnológico, envejecimiento poblacional y transformación cultural. Revista de Ciencias Sociales 30(41), 159–178 (2017)
2.
Zurück zum Zitat Prince, M.J., Wimo, A., Guerchet, M.M., Ali, G.C., Wu, Y.-T., Prina, M.: World alzheimer report 2015-the global impact of dementia: An analysis of prevalence, incidence, cost and trends (2015) Prince, M.J., Wimo, A., Guerchet, M.M., Ali, G.C., Wu, Y.-T., Prina, M.: World alzheimer report 2015-the global impact of dementia: An analysis of prevalence, incidence, cost and trends (2015)
3.
Zurück zum Zitat Vrijsen, J., Matulessij, T., Joxhorst, T., de Rooij, S.E., Smidt, N.: Knowledge, health beliefs and attitudes towards dementia and dementia risk reduction among the dutch general population: a cross-sectional study. BMC public health 21(1), 1–11 (2021) Vrijsen, J., Matulessij, T., Joxhorst, T., de Rooij, S.E., Smidt, N.: Knowledge, health beliefs and attitudes towards dementia and dementia risk reduction among the dutch general population: a cross-sectional study. BMC public health 21(1), 1–11 (2021)
4.
Zurück zum Zitat Widiger, T.A., Costa, P.T., Association, A.P., et al: Personality Disorders and the Five-factor Model of Personality. JSTOR, (2013) Widiger, T.A., Costa, P.T., Association, A.P., et al: Personality Disorders and the Five-factor Model of Personality. JSTOR, (2013)
5.
Zurück zum Zitat Lo, R.Y.: The borderland between normal aging and dementia. Tzu-Chi Medical Journal 29(2), 65 (2017) Lo, R.Y.: The borderland between normal aging and dementia. Tzu-Chi Medical Journal 29(2), 65 (2017)
7.
Zurück zum Zitat Budson, A.E., Solomon, P.R.: Memory Loss E-book: A Practical Guide for Clinicians. Elsevier Health Sciences, (2011) Budson, A.E., Solomon, P.R.: Memory Loss E-book: A Practical Guide for Clinicians. Elsevier Health Sciences, (2011)
9.
Zurück zum Zitat Tackenberg, C., Kulic, L., Nitsch, R.M.: Familial alzheimer’s disease mutations at position 22 of the amyloid \(\beta\)-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system. PloS one 15(9), 0239584 (2020) Tackenberg, C., Kulic, L., Nitsch, R.M.: Familial alzheimer’s disease mutations at position 22 of the amyloid \(\beta\)-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system. PloS one 15(9), 0239584 (2020)
10.
Zurück zum Zitat Wang, H., Kulas, J.A., Wang, C., Holtzman, D.M., Ferris, H.A., Hansen, S.B.: Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol. Proceedings of the National Academy of Sciences 118(33) (2021) Wang, H., Kulas, J.A., Wang, C., Holtzman, D.M., Ferris, H.A., Hansen, S.B.: Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol. Proceedings of the National Academy of Sciences 118(33) (2021)
11.
Zurück zum Zitat Vilchez, D., Saez, I., Dillin, A.: The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nature communications 5(1), 1–13 (2014) Vilchez, D., Saez, I., Dillin, A.: The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nature communications 5(1), 1–13 (2014)
12.
Zurück zum Zitat Breijyeh, Z., Karaman, R.: Comprehensive review on alzheimer’s disease: Causes and treatment. Molecules 25(24), 5789 (2020) Breijyeh, Z., Karaman, R.: Comprehensive review on alzheimer’s disease: Causes and treatment. Molecules 25(24), 5789 (2020)
13.
Zurück zum Zitat Long, J.M., Holtzman, D.M.: Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2), 312–339 (2019) Long, J.M., Holtzman, D.M.: Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2), 312–339 (2019)
14.
Zurück zum Zitat Román, G.C.: Vascular dementia may be the most common form of dementia in the elderly. Journal of the neurological sciences 203, 7–10 (2002) Román, G.C.: Vascular dementia may be the most common form of dementia in the elderly. Journal of the neurological sciences 203, 7–10 (2002)
15.
Zurück zum Zitat Gold, G., Bouras, C., Canuto, A., Bergallo, M.F., Herrmann, F.R., Hof, P.R., Mayor, P.-A., Michel, J.-P., Giannakopoulos, P.: Clinicopathological validation study of four sets of clinical criteria for vascular dementia. American Journal of Psychiatry 159(1), 82–87 (2002) Gold, G., Bouras, C., Canuto, A., Bergallo, M.F., Herrmann, F.R., Hof, P.R., Mayor, P.-A., Michel, J.-P., Giannakopoulos, P.: Clinicopathological validation study of four sets of clinical criteria for vascular dementia. American Journal of Psychiatry 159(1), 82–87 (2002)
16.
Zurück zum Zitat Lina, R.: Atrial fibrillation in aging; methodological aspects and the relation to dementia and cerebral vascular disease (2022) Lina, R.: Atrial fibrillation in aging; methodological aspects and the relation to dementia and cerebral vascular disease (2022)
17.
Zurück zum Zitat Kuźma, E., Lourida, I., Moore, S.F., Levine, D.A., Ukoumunne, O.C., Llewellyn, D.J.: Stroke and dementia risk: a systematic review and meta-analysis. Alzheimer’s & Dementia 14(11), 1416–1426 (2018) Kuźma, E., Lourida, I., Moore, S.F., Levine, D.A., Ukoumunne, O.C., Llewellyn, D.J.: Stroke and dementia risk: a systematic review and meta-analysis. Alzheimer’s & Dementia 14(11), 1416–1426 (2018)
18.
Zurück zum Zitat Tay, J., Morris, R.G., Tuladhar, A.M., Husain, M., de Leeuw, F.-E., Markus, H.S.: Apathy, but not depression, predicts all-cause dementia in cerebral small vessel disease. Journal of Neurology, Neurosurgery & Psychiatry 91(9), 953–959 (2020) Tay, J., Morris, R.G., Tuladhar, A.M., Husain, M., de Leeuw, F.-E., Markus, H.S.: Apathy, but not depression, predicts all-cause dementia in cerebral small vessel disease. Journal of Neurology, Neurosurgery & Psychiatry 91(9), 953–959 (2020)
19.
Zurück zum Zitat Morton, R.E., St. John, P.D., Tyas, S.L.: Migraine and the risk of all-cause dementia, alzheimer’s disease, and vascular dementia: A prospective cohort study in community-dwelling older adults. International journal of geriatric psychiatry 34(11), 1667–1676 (2019) Morton, R.E., St. John, P.D., Tyas, S.L.: Migraine and the risk of all-cause dementia, alzheimer’s disease, and vascular dementia: A prospective cohort study in community-dwelling older adults. International journal of geriatric psychiatry 34(11), 1667–1676 (2019)
20.
Zurück zum Zitat Sanford, A.M.: Lewy body dementia. Clinics in geriatric medicine 34(4), 603–615 (2018) Sanford, A.M.: Lewy body dementia. Clinics in geriatric medicine 34(4), 603–615 (2018)
21.
Zurück zum Zitat Taylor, J.-P., McKeith, I.G., Burn, D.J., Boeve, B.F., Weintraub, D., Bamford, C., Allan, L.M., Thomas, A.J., T O’Brien, J.: New evidence on the management of lewy body dementia. The Lancet Neurology 19(2), 157–169 (2020) Taylor, J.-P., McKeith, I.G., Burn, D.J., Boeve, B.F., Weintraub, D., Bamford, C., Allan, L.M., Thomas, A.J., T O’Brien, J.: New evidence on the management of lewy body dementia. The Lancet Neurology 19(2), 157–169 (2020)
22.
Zurück zum Zitat McKEITH, I.G., Galasko, D., Wilcock, G.K., Byrne, E.J.: Lewy body dementia–diagnosis and treatment. The British Journal of Psychiatry 167(6), 709–717 (1995) McKEITH, I.G., Galasko, D., Wilcock, G.K., Byrne, E.J.: Lewy body dementia–diagnosis and treatment. The British Journal of Psychiatry 167(6), 709–717 (1995)
23.
Zurück zum Zitat Surendranathan, A., Kane, J.P., Bentley, A., Barker, S.A., Taylor, J.-P., Thomas, A.J., Allan, L.M., McNally, R.J., James, P.W., McKeith, I.G., et al.: Clinical diagnosis of lewy body dementia. BJPsych open 6(4) (2020) Surendranathan, A., Kane, J.P., Bentley, A., Barker, S.A., Taylor, J.-P., Thomas, A.J., Allan, L.M., McNally, R.J., James, P.W., McKeith, I.G., et al.: Clinical diagnosis of lewy body dementia. BJPsych open 6(4) (2020)
24.
Zurück zum Zitat Finger, E.C.: Frontotemporal dementias. Continuum: Lifelong Learning in Neurology 22(2 Dementia), 464 (2016) Finger, E.C.: Frontotemporal dementias. Continuum: Lifelong Learning in Neurology 22(2 Dementia), 464 (2016)
25.
Zurück zum Zitat Rabinovici, G.D., Miller, B.L.: Frontotemporal lobar degeneration. CNS drugs 24(5), 375–398 (2010) Rabinovici, G.D., Miller, B.L.: Frontotemporal lobar degeneration. CNS drugs 24(5), 375–398 (2010)
26.
Zurück zum Zitat Organization, W.H., et al.: The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines; 2004. Geneva: WHO (2021) Organization, W.H., et al.: The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines; 2004. Geneva: WHO (2021)
27.
Zurück zum Zitat Ghetti, B., Buratti, E., Boeve, B., Rademakers, R.: Frontotemporal Dementias vol. 320. Springer, (2021) Ghetti, B., Buratti, E., Boeve, B., Rademakers, R.: Frontotemporal Dementias vol. 320. Springer, (2021)
28.
Zurück zum Zitat Custodio, N., Montesinos, R., Lira, D., Herrera-Pérez, E., Bardales, Y., Valeriano-Lorenzo, L.: Mixed dementia: A review of the evidence. Dementia & neuropsychologia 11, 364–370 (2017) Custodio, N., Montesinos, R., Lira, D., Herrera-Pérez, E., Bardales, Y., Valeriano-Lorenzo, L.: Mixed dementia: A review of the evidence. Dementia & neuropsychologia 11, 364–370 (2017)
29.
Zurück zum Zitat Garcia-Ptacek, S., Kåreholt, I., Cermakova, P., Rizzuto, D., Religa, D., Eriksdotter, M.: Causes of death according to death certificates in individuals with dementia: a cohort from the swedish dementia registry. Journal of the American Geriatrics Society 64(11), 137–142 (2016) Garcia-Ptacek, S., Kåreholt, I., Cermakova, P., Rizzuto, D., Religa, D., Eriksdotter, M.: Causes of death according to death certificates in individuals with dementia: a cohort from the swedish dementia registry. Journal of the American Geriatrics Society 64(11), 137–142 (2016)
30.
Zurück zum Zitat Arvanitakis, Z., Shah, R.C., Bennett, D.A.: Diagnosis and management of dementia. Jama 322(16), 1589–1599 (2019) Arvanitakis, Z., Shah, R.C., Bennett, D.A.: Diagnosis and management of dementia. Jama 322(16), 1589–1599 (2019)
31.
Zurück zum Zitat Ullah, H., Bin Heyat, M.B., AlSalman, H., Khan, H.M., Akhtar, F., Gumaei, A., Mehdi, A., Muaad, A.Y., Islam, M.S., Ali, A., et al.: An effective and lightweight deep electrocardiography arrhythmia recognition model using novel special and native structural regularization techniques on cardiac signal. Journal of Healthcare Engineering 2022 (2022) Ullah, H., Bin Heyat, M.B., AlSalman, H., Khan, H.M., Akhtar, F., Gumaei, A., Mehdi, A., Muaad, A.Y., Islam, M.S., Ali, A., et al.: An effective and lightweight deep electrocardiography arrhythmia recognition model using novel special and native structural regularization techniques on cardiac signal. Journal of Healthcare Engineering 2022 (2022)
32.
Zurück zum Zitat Javeed, A., Ali, L., Mohammed Seid, A., Ali, A., Khan, D., Imrana, Y.: A clinical decision support system (cdss) for unbiased prediction of caesarean section based on features extraction and optimized classification. Computational Intelligence and Neuroscience 2022 (2022) Javeed, A., Ali, L., Mohammed Seid, A., Ali, A., Khan, D., Imrana, Y.: A clinical decision support system (cdss) for unbiased prediction of caesarean section based on features extraction and optimized classification. Computational Intelligence and Neuroscience 2022 (2022)
33.
Zurück zum Zitat Imrana, Y., Xiang, Y., Ali, L., Abdul-Rauf, Z., Hu, Y.-C., Kadry, S., Lim, S.: \(\chi\) 2-bidlstm: A feature driven intrusion detection system based on \(\chi\) 2 statistical model and bidirectional lstm. Sensors 22(5), 2018 (2022) Imrana, Y., Xiang, Y., Ali, L., Abdul-Rauf, Z., Hu, Y.-C., Kadry, S., Lim, S.: \(\chi\) 2-bidlstm: A feature driven intrusion detection system based on \(\chi\) 2 statistical model and bidirectional lstm. Sensors 22(5), 2018 (2022)
34.
Zurück zum Zitat Ali, L., Zhu, C., Zhao, H., Zhang, Z., Liu, Y.: An integrated system for unbiased parkinson’s disease detection from handwritten drawings. In: Advances in Intelligent Systems and Computing, pp. 3–13. Springer, (2022) Ali, L., Zhu, C., Zhao, H., Zhang, Z., Liu, Y.: An integrated system for unbiased parkinson’s disease detection from handwritten drawings. In: Advances in Intelligent Systems and Computing, pp. 3–13. Springer, (2022)
35.
Zurück zum Zitat Ali, L., Niamat, A., Khan, J.A., Golilarz, N.A., Xingzhong, X., Noor, A., Nour, R., Bukhari, S.A.C.: An optimized stacked support vector machines based expert system for the effective prediction of heart failure. IEEE Access 7, 54007–54014 (2019) Ali, L., Niamat, A., Khan, J.A., Golilarz, N.A., Xingzhong, X., Noor, A., Nour, R., Bukhari, S.A.C.: An optimized stacked support vector machines based expert system for the effective prediction of heart failure. IEEE Access 7, 54007–54014 (2019)
36.
Zurück zum Zitat Ali, L., Zhu, C., Zhou, M., Liu, Y.: Early diagnosis of parkinson’s disease from multiple voice recordings by simultaneous sample and feature selection. Expert Systems with Applications 137, 22–28 (2019) Ali, L., Zhu, C., Zhou, M., Liu, Y.: Early diagnosis of parkinson’s disease from multiple voice recordings by simultaneous sample and feature selection. Expert Systems with Applications 137, 22–28 (2019)
37.
Zurück zum Zitat Ali, L., Khan, S.U., Golilarz, N.A., Yakubu, I., Qasim, I., Noor, A., Nour, R.: A feature-driven decision support system for heart failure prediction based on statistical model and gaussian naive bayes. Computational and Mathematical Methods in Medicine 2019 (2019) Ali, L., Khan, S.U., Golilarz, N.A., Yakubu, I., Qasim, I., Noor, A., Nour, R.: A feature-driven decision support system for heart failure prediction based on statistical model and gaussian naive bayes. Computational and Mathematical Methods in Medicine 2019 (2019)
38.
Zurück zum Zitat Mehbodniya, A., Khan, I.R., Chakraborty, S., Karthik, M., Mehta, K., Ali, L., Nuagah, S.J.: Data mining in employee healthcare detection using intelligence techniques for industry development. Journal of Healthcare Engineering 2022 (2022) Mehbodniya, A., Khan, I.R., Chakraborty, S., Karthik, M., Mehta, K., Ali, L., Nuagah, S.J.: Data mining in employee healthcare detection using intelligence techniques for industry development. Journal of Healthcare Engineering 2022 (2022)
39.
Zurück zum Zitat Ali, L., Khan, S.U., Arshad, M., Ali, S., Anwar, M.: A multi-model framework for evaluating type of speech samples having complementary information about parkinson’s disease. In: 2019 International Conference on Electrical, Communication, and Computer Engineering (ICECCE), pp. 1–5 (2019). IEEE Ali, L., Khan, S.U., Arshad, M., Ali, S., Anwar, M.: A multi-model framework for evaluating type of speech samples having complementary information about parkinson’s disease. In: 2019 International Conference on Electrical, Communication, and Computer Engineering (ICECCE), pp. 1–5 (2019). IEEE
40.
Zurück zum Zitat Ahmad, F.S., Ali, L., Khattak, H.A., Hameed, T., Wajahat, I., Kadry, S., Bukhari, S.A.C., et al: A hybrid machine learning framework to predict mortality in paralytic ileus patients using electronic health records (ehrs). Journal of Ambient Intelligence and Humanized Computing 12(3), 3283–3293 (2021) Ahmad, F.S., Ali, L., Khattak, H.A., Hameed, T., Wajahat, I., Kadry, S., Bukhari, S.A.C., et al: A hybrid machine learning framework to predict mortality in paralytic ileus patients using electronic health records (ehrs). Journal of Ambient Intelligence and Humanized Computing 12(3), 3283–3293 (2021)
41.
Zurück zum Zitat Ali, L., Wajahat, I., Golilarz, N.A., Keshtkar, F., Bukhari, S.A.C.: Lda–ga–svm: improved hepatocellular carcinoma prediction through dimensionality reduction and genetically optimized support vector machine. Neural Computing and Applications 33(7), 2783–2792 (2021) Ali, L., Wajahat, I., Golilarz, N.A., Keshtkar, F., Bukhari, S.A.C.: Lda–ga–svm: improved hepatocellular carcinoma prediction through dimensionality reduction and genetically optimized support vector machine. Neural Computing and Applications 33(7), 2783–2792 (2021)
42.
Zurück zum Zitat Ali, L., Zhu, C., Zhang, Z., Liu, Y.: Automated detection of parkinson’s disease based on multiple types of sustained phonations using linear discriminant analysis and genetically optimized neural network. IEEE journal of translational engineering in health and medicine 7, 1–10 (2019) Ali, L., Zhu, C., Zhang, Z., Liu, Y.: Automated detection of parkinson’s disease based on multiple types of sustained phonations using linear discriminant analysis and genetically optimized neural network. IEEE journal of translational engineering in health and medicine 7, 1–10 (2019)
43.
Zurück zum Zitat Ali, L., He, Z., Cao, W., Rauf, H.T., Imrana, Y., Heyat, M.B.B.: Mmdd-ensemble: A multimodal data–driven ensemble approach for parkinson’s disease detection. Frontiers in Neuroscience 15 (2021) Ali, L., He, Z., Cao, W., Rauf, H.T., Imrana, Y., Heyat, M.B.B.: Mmdd-ensemble: A multimodal data–driven ensemble approach for parkinson’s disease detection. Frontiers in Neuroscience 15 (2021)
44.
Zurück zum Zitat Rehman, A., Khan, A., Ali, M.A., Khan, M.U., Khan, S.U., Ali, L.: Performance analysis of pca, sparse pca, kernel pca and incremental pca algorithms for heart failure prediction. In: 2020 International Conference on Electrical, Communication, and Computer Engineering (ICECCE), pp. 1–5 (2020). IEEE Rehman, A., Khan, A., Ali, M.A., Khan, M.U., Khan, S.U., Ali, L.: Performance analysis of pca, sparse pca, kernel pca and incremental pca algorithms for heart failure prediction. In: 2020 International Conference on Electrical, Communication, and Computer Engineering (ICECCE), pp. 1–5 (2020). IEEE
45.
Zurück zum Zitat Ahmed, F.S., Ali, L., Joseph, B.A., Ikram, A., Mustafa, R.U., Bukhari, S.A.C.: A statistically rigorous deep neural network approach to predict mortality in trauma patients admitted to the intensive care unit. Journal of Trauma and Acute Care Surgery 89(4), 736–742 (2020) Ahmed, F.S., Ali, L., Joseph, B.A., Ikram, A., Mustafa, R.U., Bukhari, S.A.C.: A statistically rigorous deep neural network approach to predict mortality in trauma patients admitted to the intensive care unit. Journal of Trauma and Acute Care Surgery 89(4), 736–742 (2020)
46.
Zurück zum Zitat Imrana, Y., Xiang, Y., Ali, L., Abdul-Rauf, Z.: A bidirectional lstm deep learning approach for intrusion detection. Expert Systems with Applications 185, 115524 (2021) Imrana, Y., Xiang, Y., Ali, L., Abdul-Rauf, Z.: A bidirectional lstm deep learning approach for intrusion detection. Expert Systems with Applications 185, 115524 (2021)
47.
Zurück zum Zitat Akbar, W., Wu, W.-p., Saleem, S., Farhan, M., Saleem, M.A., Javeed, A., Ali, L.: Development of hepatitis disease detection system by exploiting sparsity in linear support vector machine to improve strength of adaboost ensemble model. Mobile Information Systems 2020 (2020) Akbar, W., Wu, W.-p., Saleem, S., Farhan, M., Saleem, M.A., Javeed, A., Ali, L.: Development of hepatitis disease detection system by exploiting sparsity in linear support vector machine to improve strength of adaboost ensemble model. Mobile Information Systems 2020 (2020)
48.
Zurück zum Zitat Ali, L., Bukhari, S.: An approach based on mutually informed neural networks to optimize the generalization capabilities of decision support systems developed for heart failure prediction. Irbm 42(5), 345–352 (2021) Ali, L., Bukhari, S.: An approach based on mutually informed neural networks to optimize the generalization capabilities of decision support systems developed for heart failure prediction. Irbm 42(5), 345–352 (2021)
49.
Zurück zum Zitat McInnes, M.D., Moher, D., Thombs, B.D., McGrath, T.A., Bossuyt, P.M., Clifford, T., Cohen, J.F., Deeks, J.J., Gatsonis, C., Hooft, L., et al: Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the prisma-dta statement. Jama 319(4), 388–396 (2018) McInnes, M.D., Moher, D., Thombs, B.D., McGrath, T.A., Bossuyt, P.M., Clifford, T., Cohen, J.F., Deeks, J.J., Gatsonis, C., Hooft, L., et al: Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the prisma-dta statement. Jama 319(4), 388–396 (2018)
50.
Zurück zum Zitat Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P., Clarke, M., Devereaux, P.J., Kleijnen, J., Moher, D.: The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of clinical epidemiology 62(10), 1–34 (2009) Liberati, A., Altman, D.G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.C., Ioannidis, J.P., Clarke, M., Devereaux, P.J., Kleijnen, J., Moher, D.: The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of clinical epidemiology 62(10), 1–34 (2009)
51.
Zurück zum Zitat Martí-Juan, G., Sanroma-Guell, G., Piella, G.: A survey on machine and statistical learning for longitudinal analysis of neuroimaging data in alzheimer’s disease. Computer methods and programs in biomedicine 189, 105348 (2020) Martí-Juan, G., Sanroma-Guell, G., Piella, G.: A survey on machine and statistical learning for longitudinal analysis of neuroimaging data in alzheimer’s disease. Computer methods and programs in biomedicine 189, 105348 (2020)
52.
Zurück zum Zitat McGinnis, J.M., Olsen, L., Goolsby, W.A., Grossmann, C., et al: Clinical Data as the Basic Staple of Health Learning: Creating and Protecting a Public Good: Workshop Summary. National Academies Press, (2011) McGinnis, J.M., Olsen, L., Goolsby, W.A., Grossmann, C., et al: Clinical Data as the Basic Staple of Health Learning: Creating and Protecting a Public Good: Workshop Summary. National Academies Press, (2011)
53.
Zurück zum Zitat Vaughn, V.M., Linder, J.A.: Thoughtless design of the electronic health record drives overuse, but purposeful design can nudge improved patient care. BMJ Publishing Group Ltd (2018) Vaughn, V.M., Linder, J.A.: Thoughtless design of the electronic health record drives overuse, but purposeful design can nudge improved patient care. BMJ Publishing Group Ltd (2018)
54.
Zurück zum Zitat Doody, R., Stevens, J., Beck, C., Dubinsky, R., Kaye, J., Gwyther, L., Mohs, R., Thal, L., Whitehouse, P., DeKosky, S., et al: Practice parameter: Management of dementia (an evidence-based review): Report of the quality standards subcommittee of the american academy of neurology. Neurology 56(9), 1154–1166 (2001) Doody, R., Stevens, J., Beck, C., Dubinsky, R., Kaye, J., Gwyther, L., Mohs, R., Thal, L., Whitehouse, P., DeKosky, S., et al: Practice parameter: Management of dementia (an evidence-based review): Report of the quality standards subcommittee of the american academy of neurology. Neurology 56(9), 1154–1166 (2001)
55.
Zurück zum Zitat Chi, C.-L., Zeng, W., Oh, W., Borson, S., Lenskaia, T., Shen, X., Tonellato, P.J.: Personalized long-term prediction of cognitive function: Using sequential assessments to improve model performance. Journal of biomedical informatics 76, 78–86 (2017) Chi, C.-L., Zeng, W., Oh, W., Borson, S., Lenskaia, T., Shen, X., Tonellato, P.J.: Personalized long-term prediction of cognitive function: Using sequential assessments to improve model performance. Journal of biomedical informatics 76, 78–86 (2017)
56.
Zurück zum Zitat Johnson, K.A., Minoshima, S., Bohnen, N.I., Donohoe, K.J., Foster, N.L., Herscovitch, P., Karlawish, J.H., Rowe, C.C., Carrillo, M.C., Hartley, D.M., et al: Appropriate use criteria for amyloid pet: a report of the amyloid imaging task force, the society of nuclear medicine and molecular imaging, and the alzheimer’s association. Alzheimer’s & Dementia 9(1), 1–16 (2013) Johnson, K.A., Minoshima, S., Bohnen, N.I., Donohoe, K.J., Foster, N.L., Herscovitch, P., Karlawish, J.H., Rowe, C.C., Carrillo, M.C., Hartley, D.M., et al: Appropriate use criteria for amyloid pet: a report of the amyloid imaging task force, the society of nuclear medicine and molecular imaging, and the alzheimer’s association. Alzheimer’s & Dementia 9(1), 1–16 (2013)
57.
Zurück zum Zitat Shaw, L.M., Arias, J., Blennow, K., Galasko, D., Molinuevo, J.L., Salloway, S., Schindler, S., Carrillo, M.C., Hendrix, J.A., Ross, A., et al: Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of alzheimer’s disease. Alzheimer’s & Dementia 14(11), 1505–1521 (2018) Shaw, L.M., Arias, J., Blennow, K., Galasko, D., Molinuevo, J.L., Salloway, S., Schindler, S., Carrillo, M.C., Hendrix, J.A., Ross, A., et al: Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of alzheimer’s disease. Alzheimer’s & Dementia 14(11), 1505–1521 (2018)
58.
Zurück zum Zitat Mills, K.L., Tamnes, C.K.: Methods and considerations for longitudinal structural brain imaging analysis across development. Developmental cognitive neuroscience 9, 172–190 (2014) Mills, K.L., Tamnes, C.K.: Methods and considerations for longitudinal structural brain imaging analysis across development. Developmental cognitive neuroscience 9, 172–190 (2014)
59.
Zurück zum Zitat Ali, L., Zhu, C., Golilarz, N.A., Javeed, A., Zhou, M., Liu, Y.: Reliable parkinson’s disease detection by analyzing handwritten drawings: construction of an unbiased cascaded learning system based on feature selection and adaptive boosting model. Ieee Access 7, 116480–116489 (2019) Ali, L., Zhu, C., Golilarz, N.A., Javeed, A., Zhou, M., Liu, Y.: Reliable parkinson’s disease detection by analyzing handwritten drawings: construction of an unbiased cascaded learning system based on feature selection and adaptive boosting model. Ieee Access 7, 116480–116489 (2019)
60.
Zurück zum Zitat Javeed, A., Rizvi, S.S., Zhou, S., Riaz, R., Khan, S.U., Kwon, S.J.: Heart risk failure prediction using a novel feature selection method for feature refinement and neural network for classification. Mobile Information Systems 2020 (2020) Javeed, A., Rizvi, S.S., Zhou, S., Riaz, R., Khan, S.U., Kwon, S.J.: Heart risk failure prediction using a novel feature selection method for feature refinement and neural network for classification. Mobile Information Systems 2020 (2020)
61.
Zurück zum Zitat Javeed, A., Zhou, S., Yongjian, L., Qasim, I., Noor, A., Nour, R.: An intelligent learning system based on random search algorithm and optimized random forest model for improved heart disease detection. IEEE Access 7, 180235–180243 (2019) Javeed, A., Zhou, S., Yongjian, L., Qasim, I., Noor, A., Nour, R.: An intelligent learning system based on random search algorithm and optimized random forest model for improved heart disease detection. IEEE Access 7, 180235–180243 (2019)
62.
Zurück zum Zitat Ali, L., Rahman, A., Khan, A., Zhou, M., Javeed, A., Khan, J.A.: An automated diagnostic system for heart disease prediction based on chi2 statistical model and optimally configured deep neural network. IEEE Access 7, 34938–34945 (2019) Ali, L., Rahman, A., Khan, A., Zhou, M., Javeed, A., Khan, J.A.: An automated diagnostic system for heart disease prediction based on chi2 statistical model and optimally configured deep neural network. IEEE Access 7, 34938–34945 (2019)
63.
Zurück zum Zitat Maddox, T.M., Rumsfeld, J.S., Payne, P.R.: Questions for artificial intelligence in health care. Jama 321(1), 31–32 (2019) Maddox, T.M., Rumsfeld, J.S., Payne, P.R.: Questions for artificial intelligence in health care. Jama 321(1), 31–32 (2019)
64.
Zurück zum Zitat Chen, P.-H.C., Liu, Y., Peng, L.: How to develop machine learning models for healthcare. Nature materials 18(5), 410–414 (2019) Chen, P.-H.C., Liu, Y., Peng, L.: How to develop machine learning models for healthcare. Nature materials 18(5), 410–414 (2019)
65.
Zurück zum Zitat Javeed, A., Khan, S.U., Ali, L., Ali, S., Imrana, Y., Rahman, A.: Machine learning-based automated diagnostic systems developed for heart failure prediction using different types of data modalities: A systematic review and future directions. Computational and Mathematical Methods in Medicine 2022 (2022) Javeed, A., Khan, S.U., Ali, L., Ali, S., Imrana, Y., Rahman, A.: Machine learning-based automated diagnostic systems developed for heart failure prediction using different types of data modalities: A systematic review and future directions. Computational and Mathematical Methods in Medicine 2022 (2022)
66.
Zurück zum Zitat Thacker, S.B., Qualters, J.R., Lee, L.M., for Disease Control, C., Prevention, et al: Public health surveillance in the united states: evolution and challenges. MMWR Suppl 61(3), 3–9 (2012) Thacker, S.B., Qualters, J.R., Lee, L.M., for Disease Control, C., Prevention, et al: Public health surveillance in the united states: evolution and challenges. MMWR Suppl 61(3), 3–9 (2012)
67.
Zurück zum Zitat Boerma, J.T., Stansfield, S.K.: Health statistics now: are we making the right investments? The Lancet 369(9563), 779–786 (2007) Boerma, J.T., Stansfield, S.K.: Health statistics now: are we making the right investments? The Lancet 369(9563), 779–786 (2007)
68.
Zurück zum Zitat Walport, M., Brest, P.: Sharing research data to improve public health. The Lancet 377(9765), 537–539 (2011) Walport, M., Brest, P.: Sharing research data to improve public health. The Lancet 377(9765), 537–539 (2011)
69.
Zurück zum Zitat Van Panhuis, W.G., Paul, P., Emerson, C., Grefenstette, J., Wilder, R., Herbst, A.J., Heymann, D., Burke, D.S.: A systematic review of barriers to data sharing in public health. BMC public health 14(1), 1–9 (2014) Van Panhuis, W.G., Paul, P., Emerson, C., Grefenstette, J., Wilder, R., Herbst, A.J., Heymann, D., Burke, D.S.: A systematic review of barriers to data sharing in public health. BMC public health 14(1), 1–9 (2014)
70.
Zurück zum Zitat Dashtipour, K., Taylor, W., Ansari, S., Zahid, A., Gogate, M., Ahmad, J., Assaleh, K., Arshad, K., Imran, M.A., Abbai, Q.: Detecting alzheimer’s disease using machine learning methods. In: EAI (2021) Dashtipour, K., Taylor, W., Ansari, S., Zahid, A., Gogate, M., Ahmad, J., Assaleh, K., Arshad, K., Imran, M.A., Abbai, Q.: Detecting alzheimer’s disease using machine learning methods. In: EAI (2021)
71.
Zurück zum Zitat Helaly, H.A., Badawy, M., Haikal, A.Y.: Deep learning approach for early detection of alzheimer’s disease. Cognitive Computation, 1–17 (2021) Helaly, H.A., Badawy, M., Haikal, A.Y.: Deep learning approach for early detection of alzheimer’s disease. Cognitive Computation, 1–17 (2021)
72.
Zurück zum Zitat Vandenberghe, R., Nelissen, N., Salmon, E., Ivanoiu, A., Hasselbalch, S., Andersen, A., Korner, A., Minthon, L., Brooks, D.J., Van Laere, K., et al: Binary classification of 18f-flutemetamol pet using machine learning: comparison with visual reads and structural mri. Neuroimage 64, 517–525 (2013) Vandenberghe, R., Nelissen, N., Salmon, E., Ivanoiu, A., Hasselbalch, S., Andersen, A., Korner, A., Minthon, L., Brooks, D.J., Van Laere, K., et al: Binary classification of 18f-flutemetamol pet using machine learning: comparison with visual reads and structural mri. Neuroimage 64, 517–525 (2013)
73.
Zurück zum Zitat Odusami, M., Maskeliūnas, R., Damaševičius, R., Krilavičius, T.: Analysis of features of alzheimer’s disease: Detection of early stage from functional brain changes in magnetic resonance images using a finetuned resnet18 network. Diagnostics 11(6), 1071 (2021) Odusami, M., Maskeliūnas, R., Damaševičius, R., Krilavičius, T.: Analysis of features of alzheimer’s disease: Detection of early stage from functional brain changes in magnetic resonance images using a finetuned resnet18 network. Diagnostics 11(6), 1071 (2021)
74.
Zurück zum Zitat Zheng, Y., Guo, H., Zhang, L., Wu, J., Li, Q., Lv, F.: Machine learning-based framework for differential diagnosis between vascular dementia and alzheimer’s disease using structural mri features. Frontiers in Neurology, 1097 (2019) Zheng, Y., Guo, H., Zhang, L., Wu, J., Li, Q., Lv, F.: Machine learning-based framework for differential diagnosis between vascular dementia and alzheimer’s disease using structural mri features. Frontiers in Neurology, 1097 (2019)
75.
Zurück zum Zitat Basheer, S., Bhatia, S., Sakri, S.B.: Computational modeling of dementia prediction using deep neural network: Analysis on oasis dataset. IEEE Access 9, 42449–42462 (2021) Basheer, S., Bhatia, S., Sakri, S.B.: Computational modeling of dementia prediction using deep neural network: Analysis on oasis dataset. IEEE Access 9, 42449–42462 (2021)
76.
Zurück zum Zitat Leong, L.K., Abdullah, A.A.: Prediction of alzheimer’s disease (ad) using machine learning techniques with boruta algorithm as feature selection method. In: Journal of Physics: Conference Series, vol. 1372, p. 012065 (2019). IOP Publishing Leong, L.K., Abdullah, A.A.: Prediction of alzheimer’s disease (ad) using machine learning techniques with boruta algorithm as feature selection method. In: Journal of Physics: Conference Series, vol. 1372, p. 012065 (2019). IOP Publishing
77.
Zurück zum Zitat Battineni, G., Chintalapudi, N., Amenta, F.: Machine learning in medicine: Performance calculation of dementia prediction by support vector machines (svm). Informatics in Medicine Unlocked 16, 100200 (2019) Battineni, G., Chintalapudi, N., Amenta, F.: Machine learning in medicine: Performance calculation of dementia prediction by support vector machines (svm). Informatics in Medicine Unlocked 16, 100200 (2019)
78.
Zurück zum Zitat Mathotaarachchi, S., Pascoal, T.A., Shin, M., Benedet, A.L., Kang, M.S., Beaudry, T., Fonov, V.S., Gauthier, S., Rosa-Neto, P., Initiative, A.D.N., et al: Identifying incipient dementia individuals using machine learning and amyloid imaging. Neurobiology of aging 59, 80–90 (2017) Mathotaarachchi, S., Pascoal, T.A., Shin, M., Benedet, A.L., Kang, M.S., Beaudry, T., Fonov, V.S., Gauthier, S., Rosa-Neto, P., Initiative, A.D.N., et al: Identifying incipient dementia individuals using machine learning and amyloid imaging. Neurobiology of aging 59, 80–90 (2017)
79.
Zurück zum Zitat Aruna, S., Chitra, S.: Machine learning approach for identifying dementia from mri images. International Journal of Computer and Information Engineering 9(3), 881–888 (2016) Aruna, S., Chitra, S.: Machine learning approach for identifying dementia from mri images. International Journal of Computer and Information Engineering 9(3), 881–888 (2016)
80.
Zurück zum Zitat Herzog, N.J., Magoulas, G.D.: Brain asymmetry detection and machine learning classification for diagnosis of early dementia. Sensors 21(3), 778 (2021) Herzog, N.J., Magoulas, G.D.: Brain asymmetry detection and machine learning classification for diagnosis of early dementia. Sensors 21(3), 778 (2021)
81.
Zurück zum Zitat Battineni, G., Chintalapudi, N., Amenta, F., Traini, E.: A comprehensive machine-learning model applied to magnetic resonance imaging (mri) to predict alzheimer’s disease (ad) in older subjects. Journal of Clinical Medicine 9(7), 2146 (2020) Battineni, G., Chintalapudi, N., Amenta, F., Traini, E.: A comprehensive machine-learning model applied to magnetic resonance imaging (mri) to predict alzheimer’s disease (ad) in older subjects. Journal of Clinical Medicine 9(7), 2146 (2020)
82.
Zurück zum Zitat Ma, D., Yee, E., Stocks, J.K., Jenkins, L.M., Popuri, K., Chausse, G., Wang, L., Probst, S., Beg, M.F.: Blinded clinical evaluation for dementia of alzheimer’s type classification using fdg-pet: A comparison between feature-engineered and non-feature-engineered machine learning methods. Journal of Alzheimer’s Disease 80(2), 715–726 (2021) Ma, D., Yee, E., Stocks, J.K., Jenkins, L.M., Popuri, K., Chausse, G., Wang, L., Probst, S., Beg, M.F.: Blinded clinical evaluation for dementia of alzheimer’s type classification using fdg-pet: A comparison between feature-engineered and non-feature-engineered machine learning methods. Journal of Alzheimer’s Disease 80(2), 715–726 (2021)
83.
Zurück zum Zitat Bidani, A., Gouider, M.S., Travieso-González, C.M.: Dementia detection and classification from mri images using deep neural networks and transfer learning. In: International Work-Conference on Artificial Neural Networks, pp. 925–933 (2019). Springer Bidani, A., Gouider, M.S., Travieso-González, C.M.: Dementia detection and classification from mri images using deep neural networks and transfer learning. In: International Work-Conference on Artificial Neural Networks, pp. 925–933 (2019). Springer
84.
Zurück zum Zitat Moscoso, A., Silva-Rodríguez, J., Aldrey, J.M., Cortés, J., Fernández-Ferreiro, A., Gómez-Lado, N., Ruibal, Á., Aguiar, P., Initiative, A.D.N., et al: Prediction of alzheimer’s disease dementia with mri beyond the short-term: Implications for the design of predictive models. NeuroImage: Clinical 23, 101837 (2019) Moscoso, A., Silva-Rodríguez, J., Aldrey, J.M., Cortés, J., Fernández-Ferreiro, A., Gómez-Lado, N., Ruibal, Á., Aguiar, P., Initiative, A.D.N., et al: Prediction of alzheimer’s disease dementia with mri beyond the short-term: Implications for the design of predictive models. NeuroImage: Clinical 23, 101837 (2019)
85.
Zurück zum Zitat Khan, A., Zubair, S.: An improved multi-modal based machine learning approach for the prognosis of alzheimer’s disease. Journal of King Saud University-Computer and Information Sciences (2020) Khan, A., Zubair, S.: An improved multi-modal based machine learning approach for the prognosis of alzheimer’s disease. Journal of King Saud University-Computer and Information Sciences (2020)
86.
Zurück zum Zitat Mohammed, B.A., Senan, E.M., Rassem, T.H., Makbol, N.M., Alanazi, A.A., Al-Mekhlafi, Z.G., Almurayziq, T.S., Ghaleb, F.A.: Multi-method analysis of medical records and mri images for early diagnosis of dementia and alzheimer’s disease based on deep learning and hybrid methods. Electronics 10(22), 2860 (2021) Mohammed, B.A., Senan, E.M., Rassem, T.H., Makbol, N.M., Alanazi, A.A., Al-Mekhlafi, Z.G., Almurayziq, T.S., Ghaleb, F.A.: Multi-method analysis of medical records and mri images for early diagnosis of dementia and alzheimer’s disease based on deep learning and hybrid methods. Electronics 10(22), 2860 (2021)
87.
Zurück zum Zitat Salvatore, C., Cerasa, A., Battista, P., Gilardi, M.C., Quattrone, A., Castiglioni, I.: Magnetic resonance imaging biomarkers for the early diagnosis of alzheimer’s disease: a machine learning approach. Frontiers in neuroscience 9, 307 (2015) Salvatore, C., Cerasa, A., Battista, P., Gilardi, M.C., Quattrone, A., Castiglioni, I.: Magnetic resonance imaging biomarkers for the early diagnosis of alzheimer’s disease: a machine learning approach. Frontiers in neuroscience 9, 307 (2015)
88.
Zurück zum Zitat Katako, A., Shelton, P., Goertzen, A.L., Levin, D., Bybel, B., Aljuaid, M., Yoon, H.J., Kang, D.Y., Kim, S.M., Lee, C.S., et al: Machine learning identified an alzheimer’s disease-related fdg-pet pattern which is also expressed in lewy body dementia and parkinson’s disease dementia. Scientific reports 8(1), 1–13 (2018) Katako, A., Shelton, P., Goertzen, A.L., Levin, D., Bybel, B., Aljuaid, M., Yoon, H.J., Kang, D.Y., Kim, S.M., Lee, C.S., et al: Machine learning identified an alzheimer’s disease-related fdg-pet pattern which is also expressed in lewy body dementia and parkinson’s disease dementia. Scientific reports 8(1), 1–13 (2018)
89.
Zurück zum Zitat Gray, K.R., Aljabar, P., Heckemann, R.A., Hammers, A., Rueckert, D.: Random forest-based manifold learning for classification of imaging data in dementia. In: International Workshop on Machine Learning in Medical Imaging, pp. 159–166 (2011). Springer Gray, K.R., Aljabar, P., Heckemann, R.A., Hammers, A., Rueckert, D.: Random forest-based manifold learning for classification of imaging data in dementia. In: International Workshop on Machine Learning in Medical Imaging, pp. 159–166 (2011). Springer
90.
Zurück zum Zitat De Bruijne, M.: Machine learning approaches in medical image analysis: From detection to diagnosis. Elsevier (2016) De Bruijne, M.: Machine learning approaches in medical image analysis: From detection to diagnosis. Elsevier (2016)
91.
Zurück zum Zitat Tong, T., Wolz, R., Gao, Q., Hajnal, J.V., Rueckert, D.: Multiple instance learning for classification of dementia in brain mri. In: International Conference on Medical Image Computing and Computer-Assisted Intervention, pp. 599–606 (2013). Springer Tong, T., Wolz, R., Gao, Q., Hajnal, J.V., Rueckert, D.: Multiple instance learning for classification of dementia in brain mri. In: International Conference on Medical Image Computing and Computer-Assisted Intervention, pp. 599–606 (2013). Springer
92.
Zurück zum Zitat Akhila, J., Markose, C., Aneesh, R.: Feature extraction and classification of dementia with neural network. In: 2017 International Conference on Intelligent Computing, Instrumentation and Control Technologies (ICICICT), pp. 1446–1450 (2017). IEEE Akhila, J., Markose, C., Aneesh, R.: Feature extraction and classification of dementia with neural network. In: 2017 International Conference on Intelligent Computing, Instrumentation and Control Technologies (ICICICT), pp. 1446–1450 (2017). IEEE
93.
Zurück zum Zitat Chen, Y., Pham, T.D.: Development of a brain mri-based hidden markov model for dementia recognition. Biomedical engineering online 12(1), 1–16 (2013) Chen, Y., Pham, T.D.: Development of a brain mri-based hidden markov model for dementia recognition. Biomedical engineering online 12(1), 1–16 (2013)
94.
Zurück zum Zitat Patil, M., Yardi, A.: Ann based dementia diagnosis using dct for brain mr image compression. In: 2013 International Conference on Communication and Signal Processing, pp. 451–454 (2013). IEEE Patil, M., Yardi, A.: Ann based dementia diagnosis using dct for brain mr image compression. In: 2013 International Conference on Communication and Signal Processing, pp. 451–454 (2013). IEEE
95.
Zurück zum Zitat Gulhare, K.K., Shukla, S., Sharma, L.: Deep neural network classification method to alzheimer’s disease detection. International Journals of Advanced Research in Computer Science and Software Engineering 7(6), 1–4 (2017) Gulhare, K.K., Shukla, S., Sharma, L.: Deep neural network classification method to alzheimer’s disease detection. International Journals of Advanced Research in Computer Science and Software Engineering 7(6), 1–4 (2017)
96.
Zurück zum Zitat Chiu, P.-Y., Tang, H., Wei, C.-Y., Zhang, C., Hung, G.-U., Zhou, W.: Nmd-12: A new machine-learning derived screening instrument to detect mild cognitive impairment and dementia. PloS one 14(3), 0213430 (2019) Chiu, P.-Y., Tang, H., Wei, C.-Y., Zhang, C., Hung, G.-U., Zhou, W.: Nmd-12: A new machine-learning derived screening instrument to detect mild cognitive impairment and dementia. PloS one 14(3), 0213430 (2019)
97.
Zurück zum Zitat Stamate, D., Alghamdi, W., Ogg, J., Hoile, R., Murtagh, F.: A machine learning framework for predicting dementia and mild cognitive impairment. In: 2018 17th IEEE International Conference on Machine Learning and Applications (ICMLA), pp. 671–678 (2018). IEEE Stamate, D., Alghamdi, W., Ogg, J., Hoile, R., Murtagh, F.: A machine learning framework for predicting dementia and mild cognitive impairment. In: 2018 17th IEEE International Conference on Machine Learning and Applications (ICMLA), pp. 671–678 (2018). IEEE
98.
Zurück zum Zitat Visser, P.J., Lovestone, S., Legido-Quigley, C.: A metabolite-based machine learning approach to diagnose alzheimer-type dementia in blood: Results from the european medical information framework for alzheimer disease biomarker discovery cohort (2019) Visser, P.J., Lovestone, S., Legido-Quigley, C.: A metabolite-based machine learning approach to diagnose alzheimer-type dementia in blood: Results from the european medical information framework for alzheimer disease biomarker discovery cohort (2019)
99.
Zurück zum Zitat Bansal, D., Chhikara, R., Khanna, K., Gupta, P.: Comparative analysis of various machine learning algorithms for detecting dementia. Procedia computer science 132, 1497–1502 (2018) Bansal, D., Chhikara, R., Khanna, K., Gupta, P.: Comparative analysis of various machine learning algorithms for detecting dementia. Procedia computer science 132, 1497–1502 (2018)
100.
Zurück zum Zitat Nori, V.S., Hane, C.A., Martin, D.C., Kravetz, A.D., Sanghavi, D.M.: Identifying incident dementia by applying machine learning to a very large administrative claims dataset. PLoS One 14(7), 0203246 (2019) Nori, V.S., Hane, C.A., Martin, D.C., Kravetz, A.D., Sanghavi, D.M.: Identifying incident dementia by applying machine learning to a very large administrative claims dataset. PLoS One 14(7), 0203246 (2019)
101.
Zurück zum Zitat Alam, M.A.U., Roy, N., Holmes, S., Gangopadhyay, A., Galik, E.: Automated functional and behavioral health assessment of older adults with dementia. In: 2016 IEEE First International Conference on Connected Health: Applications, Systems and Engineering Technologies (CHASE), pp. 140–149 (2016). IEEE Alam, M.A.U., Roy, N., Holmes, S., Gangopadhyay, A., Galik, E.: Automated functional and behavioral health assessment of older adults with dementia. In: 2016 IEEE First International Conference on Connected Health: Applications, Systems and Engineering Technologies (CHASE), pp. 140–149 (2016). IEEE
102.
Zurück zum Zitat Gurevich, P., Stuke, H., Kastrup, A., Stuke, H., Hildebrandt, H.: Neuropsychological testing and machine learning distinguish alzheimer’s disease from other causes for cognitive impairment. Frontiers in aging neuroscience 9, 114 (2017) Gurevich, P., Stuke, H., Kastrup, A., Stuke, H., Hildebrandt, H.: Neuropsychological testing and machine learning distinguish alzheimer’s disease from other causes for cognitive impairment. Frontiers in aging neuroscience 9, 114 (2017)
103.
Zurück zum Zitat Karaglani, M., Gourlia, K., Tsamardinos, I., Chatzaki, E.: Accurate blood-based diagnostic biosignatures for alzheimer’s disease via automated machine learning. Journal of clinical medicine 9(9), 3016 (2020) Karaglani, M., Gourlia, K., Tsamardinos, I., Chatzaki, E.: Accurate blood-based diagnostic biosignatures for alzheimer’s disease via automated machine learning. Journal of clinical medicine 9(9), 3016 (2020)
104.
Zurück zum Zitat Ryzhikova, E., Ralbovsky, N.M., Sikirzhytski, V., Kazakov, O., Halamkova, L., Quinn, J., Zimmerman, E.A., Lednev, I.K.: Raman spectroscopy and machine learning for biomedical applications: Alzheimer’s disease diagnosis based on the analysis of cerebrospinal fluid. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 248, 119188 (2021) Ryzhikova, E., Ralbovsky, N.M., Sikirzhytski, V., Kazakov, O., Halamkova, L., Quinn, J., Zimmerman, E.A., Lednev, I.K.: Raman spectroscopy and machine learning for biomedical applications: Alzheimer’s disease diagnosis based on the analysis of cerebrospinal fluid. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 248, 119188 (2021)
105.
Zurück zum Zitat Cho, P.-C., Chen, W.-H.: A double layer dementia diagnosis system using machine learning techniques. In: International Conference on Engineering Applications of Neural Networks, pp. 402–412 (2012). Springer Cho, P.-C., Chen, W.-H.: A double layer dementia diagnosis system using machine learning techniques. In: International Conference on Engineering Applications of Neural Networks, pp. 402–412 (2012). Springer
106.
Zurück zum Zitat Facal, D., Valladares-Rodriguez, S., Lojo-Seoane, C., Pereiro, A.X., Anido-Rifon, L., Juncos-Rabadán, O.: Machine learning approaches to studying the role of cognitive reserve in conversion from mild cognitive impairment to dementia. International journal of geriatric psychiatry 34(7), 941–949 (2019) Facal, D., Valladares-Rodriguez, S., Lojo-Seoane, C., Pereiro, A.X., Anido-Rifon, L., Juncos-Rabadán, O.: Machine learning approaches to studying the role of cognitive reserve in conversion from mild cognitive impairment to dementia. International journal of geriatric psychiatry 34(7), 941–949 (2019)
107.
Zurück zum Zitat Jin, H., Chien, S., Meijer, E., Khobragade, P., Lee, J., et al: Learning from clinical consensus diagnosis in india to facilitate automatic classification of dementia: Machine learning study. JMIR Mental Health 8(5), 27113 (2021) Jin, H., Chien, S., Meijer, E., Khobragade, P., Lee, J., et al: Learning from clinical consensus diagnosis in india to facilitate automatic classification of dementia: Machine learning study. JMIR Mental Health 8(5), 27113 (2021)
108.
Zurück zum Zitat James, C., Ranson, J.M., Everson, R., Llewellyn, D.J.: Performance of machine learning algorithms for predicting progression to dementia in memory clinic patients. JAMA network open 4(12), 2136553–2136553 (2021) James, C., Ranson, J.M., Everson, R., Llewellyn, D.J.: Performance of machine learning algorithms for predicting progression to dementia in memory clinic patients. JAMA network open 4(12), 2136553–2136553 (2021)
109.
Zurück zum Zitat Bougea, A., Efthymiopoulou, E., Spanou, I., Zikos, P.: A novel machine learning algorithm predicts dementia with lewy bodies versus parkinson’s disease dementia based on clinical and neuropsychological scores. Journal of geriatric psychiatry and neurology, 0891988721993556 (2021) Bougea, A., Efthymiopoulou, E., Spanou, I., Zikos, P.: A novel machine learning algorithm predicts dementia with lewy bodies versus parkinson’s disease dementia based on clinical and neuropsychological scores. Journal of geriatric psychiatry and neurology, 0891988721993556 (2021)
110.
Zurück zum Zitat Salem, F.A., Chaaya, M., Ghannam, H., Al Feel, R.E., El Asmar, K.: Regression based machine learning model for dementia diagnosis in a community setting. Alzheimer’s & Dementia 17, 053839 (2021) Salem, F.A., Chaaya, M., Ghannam, H., Al Feel, R.E., El Asmar, K.: Regression based machine learning model for dementia diagnosis in a community setting. Alzheimer’s & Dementia 17, 053839 (2021)
111.
Zurück zum Zitat Garcia-Gutierrez, F., Delgado-Alvarez, A., Delgado-Alonso, C., Díaz-Álvarez, J., Pytel, V., Valles-Salgado, M., Gil, M.J., Hernández-Lorenzo, L., Matías-Guiu, J., Ayala, J.L., et al.: Diagnosis of alzheimer’s disease and behavioural variant frontotemporal dementia with machine learning-aided neuropsychological assessment using feature engineering and genetic algorithms. International journal of geriatric psychiatry 37(2) (2022) Garcia-Gutierrez, F., Delgado-Alvarez, A., Delgado-Alonso, C., Díaz-Álvarez, J., Pytel, V., Valles-Salgado, M., Gil, M.J., Hernández-Lorenzo, L., Matías-Guiu, J., Ayala, J.L., et al.: Diagnosis of alzheimer’s disease and behavioural variant frontotemporal dementia with machine learning-aided neuropsychological assessment using feature engineering and genetic algorithms. International journal of geriatric psychiatry 37(2) (2022)
112.
Zurück zum Zitat Mirzaei, G., Adeli, H.: Machine learning techniques for diagnosis of alzheimer disease, mild cognitive disorder, and other types of dementia. Biomedical Signal Processing and Control 72, 103293 (2022) Mirzaei, G., Adeli, H.: Machine learning techniques for diagnosis of alzheimer disease, mild cognitive disorder, and other types of dementia. Biomedical Signal Processing and Control 72, 103293 (2022)
113.
Zurück zum Zitat Hsiu, H., Lin, S.-K., Weng, W.-L., Hung, C.-M., Chang, C.-K., Lee, C.-C., Chen, C.-T.: Discrimination of the cognitive function of community subjects using the arterial pulse spectrum and machine-learning analysis. Sensors 22(3), 806 (2022) Hsiu, H., Lin, S.-K., Weng, W.-L., Hung, C.-M., Chang, C.-K., Lee, C.-C., Chen, C.-T.: Discrimination of the cognitive function of community subjects using the arterial pulse spectrum and machine-learning analysis. Sensors 22(3), 806 (2022)
114.
Zurück zum Zitat Shahzad, A., Dadlani, A., Lee, H., Kim, K.: Automated prescreening of mild cognitive impairment using shank-mounted inertial sensors based gait biomarkers. IEEE Access (2022) Shahzad, A., Dadlani, A., Lee, H., Kim, K.: Automated prescreening of mild cognitive impairment using shank-mounted inertial sensors based gait biomarkers. IEEE Access (2022)
115.
Zurück zum Zitat Hane, C.A., Nori, V.S., Crown, W.H., Sanghavi, D.M., Bleicher, P.: Predicting onset of dementia using clinical notes and machine learning: case-control study. JMIR medical informatics 8(6), 17819 (2020) Hane, C.A., Nori, V.S., Crown, W.H., Sanghavi, D.M., Bleicher, P.: Predicting onset of dementia using clinical notes and machine learning: case-control study. JMIR medical informatics 8(6), 17819 (2020)
116.
Zurück zum Zitat Aschwanden, D., Aichele, S., Ghisletta, P., Terracciano, A., Kliegel, M., Sutin, A.R., Brown, J., Allemand, M.: Predicting cognitive impairment and dementia: A machine learning approach. Journal of Alzheimer’s Disease 75(3), 717–728 (2020) Aschwanden, D., Aichele, S., Ghisletta, P., Terracciano, A., Kliegel, M., Sutin, A.R., Brown, J., Allemand, M.: Predicting cognitive impairment and dementia: A machine learning approach. Journal of Alzheimer’s Disease 75(3), 717–728 (2020)
117.
Zurück zum Zitat Ryu, S.-E., Shin, D.-H., Chung, K.: Prediction model of dementia risk based on xgboost using derived variable extraction and hyper parameter optimization. IEEE Access 8, 177708–177720 (2020) Ryu, S.-E., Shin, D.-H., Chung, K.: Prediction model of dementia risk based on xgboost using derived variable extraction and hyper parameter optimization. IEEE Access 8, 177708–177720 (2020)
118.
Zurück zum Zitat de Langavant, L.C., Bayen, E., Yaffe, K., et al: Unsupervised machine learning to identify high likelihood of dementia in population-based surveys: development and validation study. Journal of medical Internet research 20(7), 10493 (2018) de Langavant, L.C., Bayen, E., Yaffe, K., et al: Unsupervised machine learning to identify high likelihood of dementia in population-based surveys: development and validation study. Journal of medical Internet research 20(7), 10493 (2018)
119.
Zurück zum Zitat Fouladvand, S., Mielke, M.M., Vassilaki, M., Sauver, J.S., Petersen, R.C., Sohn, S.: Deep learning prediction of mild cognitive impairment using electronic health records. In: 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), pp. 799–806 (2019). IEEE Fouladvand, S., Mielke, M.M., Vassilaki, M., Sauver, J.S., Petersen, R.C., Sohn, S.: Deep learning prediction of mild cognitive impairment using electronic health records. In: 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), pp. 799–806 (2019). IEEE
120.
Zurück zum Zitat Balea-Fernandez, F.J., Martinez-Vega, B., Ortega, S., Fabelo, H., Leon, R., Callico, G.M., Bibao-Sieyro, C.: Analysis of risk factors in dementia through machine learning. Journal of Alzheimer’s Disease 79(2), 845–861 (2021) Balea-Fernandez, F.J., Martinez-Vega, B., Ortega, S., Fabelo, H., Leon, R., Callico, G.M., Bibao-Sieyro, C.: Analysis of risk factors in dementia through machine learning. Journal of Alzheimer’s Disease 79(2), 845–861 (2021)
121.
Zurück zum Zitat Chlasta, K., Wołk, K.: Towards computer-based automated screening of dementia through spontaneous speech. Frontiers in Psychology, 4091 (2021) Chlasta, K., Wołk, K.: Towards computer-based automated screening of dementia through spontaneous speech. Frontiers in Psychology, 4091 (2021)
122.
Zurück zum Zitat Chien, Y.-W., Hong, S.-Y., Cheah, W.-T., Yao, L.-H., Chang, Y.-L., Fu, L.-C.: An automatic assessment system for alzheimer’s disease based on speech using feature sequence generator and recurrent neural network. Scientific Reports 9(1), 1–10 (2019) Chien, Y.-W., Hong, S.-Y., Cheah, W.-T., Yao, L.-H., Chang, Y.-L., Fu, L.-C.: An automatic assessment system for alzheimer’s disease based on speech using feature sequence generator and recurrent neural network. Scientific Reports 9(1), 1–10 (2019)
123.
Zurück zum Zitat Shimoda, A., Li, Y., Hayashi, H., Kondo, N.: Dementia risks identified by vocal features via telephone conversations: A novel machine learning prediction model. PloS one 16(7), 0253988 (2021) Shimoda, A., Li, Y., Hayashi, H., Kondo, N.: Dementia risks identified by vocal features via telephone conversations: A novel machine learning prediction model. PloS one 16(7), 0253988 (2021)
124.
Zurück zum Zitat Nishikawa, K., Akihiro, K., Hirakawa, R., Kawano, H., Nakatoh, Y.: Machine learning model for discrimination of mild dementia patients using acoustic features. Cognitive Robotics (2021) Nishikawa, K., Akihiro, K., Hirakawa, R., Kawano, H., Nakatoh, Y.: Machine learning model for discrimination of mild dementia patients using acoustic features. Cognitive Robotics (2021)
125.
Zurück zum Zitat Liu, L., Zhao, S., Chen, H., Wang, A.: A new machine learning method for identifying alzheimer’s disease. Simulation Modelling Practice and Theory 99, 102023 (2020) Liu, L., Zhao, S., Chen, H., Wang, A.: A new machine learning method for identifying alzheimer’s disease. Simulation Modelling Practice and Theory 99, 102023 (2020)
126.
Zurück zum Zitat Searle, T., Ibrahim, Z., Dobson, R.: Comparing natural language processing techniques for alzheimer’s dementia prediction in spontaneous speech. arXiv preprint arXiv:2006.07358 (2020) Searle, T., Ibrahim, Z., Dobson, R.: Comparing natural language processing techniques for alzheimer’s dementia prediction in spontaneous speech. arXiv preprint arXiv:​2006.​07358 (2020)
127.
Zurück zum Zitat Zhu, Y., Tran, B., Liang, X., Batsis, J.A., Roth, R.M.: Towards interpretability of speech pause in dementia detection using adversarial learning. arXiv preprint arXiv:2111.07454 (2021) Zhu, Y., Tran, B., Liang, X., Batsis, J.A., Roth, R.M.: Towards interpretability of speech pause in dementia detection using adversarial learning. arXiv preprint arXiv:​2111.​07454 (2021)
128.
Zurück zum Zitat Ossewaarde, R., Jonkers, R., Jalvingh, F., Bastiaanse, R.: Classification of spontaneous speech of individuals with dementia based on automatic prosody analysis using support vector machines (svm). In: The Thirty-Second International Flairs Conference (2019) Ossewaarde, R., Jonkers, R., Jalvingh, F., Bastiaanse, R.: Classification of spontaneous speech of individuals with dementia based on automatic prosody analysis using support vector machines (svm). In: The Thirty-Second International Flairs Conference (2019)
129.
Zurück zum Zitat Xue, C., Karjadi, C., Paschalidis, I.C., Au, R., Kolachalama, V.B.: Detection of dementia on voice recordings using deep learning: a framingham heart study. Alzheimer’s research & therapy 13(1), 1–15 (2021) Xue, C., Karjadi, C., Paschalidis, I.C., Au, R., Kolachalama, V.B.: Detection of dementia on voice recordings using deep learning: a framingham heart study. Alzheimer’s research & therapy 13(1), 1–15 (2021)
130.
Zurück zum Zitat Weiner, J., Engelbart, M., Schultz, T.: Manual and automatic transcriptions in dementia detection from speech. In: INTERSPEECH, pp. 3117–3121 (2017) Weiner, J., Engelbart, M., Schultz, T.: Manual and automatic transcriptions in dementia detection from speech. In: INTERSPEECH, pp. 3117–3121 (2017)
131.
Zurück zum Zitat Sadeghian, R., Schaffer, J.D., Zahorian, S.A.: Speech processing approach for diagnosing dementia in an early stage (2017) Sadeghian, R., Schaffer, J.D., Zahorian, S.A.: Speech processing approach for diagnosing dementia in an early stage (2017)
132.
Zurück zum Zitat Khodabakhsh, A., Yesil, F., Guner, E., Demiroglu, C.: Evaluation of linguistic and prosodic features for detection of alzheimer’s disease in turkish conversational speech. EURASIP Journal on Audio, Speech, and Music Processing 2015(1), 1–15 (2015) Khodabakhsh, A., Yesil, F., Guner, E., Demiroglu, C.: Evaluation of linguistic and prosodic features for detection of alzheimer’s disease in turkish conversational speech. EURASIP Journal on Audio, Speech, and Music Processing 2015(1), 1–15 (2015)
133.
Zurück zum Zitat Edwards, E., Dognin, C., Bollepalli, B., Singh, M.K., Analytics, V.: Multiscale system for alzheimer’s dementia recognition through spontaneous speech. In: INTERSPEECH, pp. 2197–2201 (2020) Edwards, E., Dognin, C., Bollepalli, B., Singh, M.K., Analytics, V.: Multiscale system for alzheimer’s dementia recognition through spontaneous speech. In: INTERSPEECH, pp. 2197–2201 (2020)
134.
Zurück zum Zitat Kumar, Y., Maheshwari, P., Joshi, S., Baths, V.: Ml-based analysis to identify speech features relevant in predicting alzheimer’s disease. arXiv preprint arXiv:2110.13023 (2021) Kumar, Y., Maheshwari, P., Joshi, S., Baths, V.: Ml-based analysis to identify speech features relevant in predicting alzheimer’s disease. arXiv preprint arXiv:​2110.​13023 (2021)
135.
Zurück zum Zitat Luz, S., de la Fuente, S., Albert, P.: A method for analysis of patient speech in dialogue for dementia detection. arXiv preprint arXiv:1811.09919 (2018) Luz, S., de la Fuente, S., Albert, P.: A method for analysis of patient speech in dialogue for dementia detection. arXiv preprint arXiv:​1811.​09919 (2018)
136.
Zurück zum Zitat Syed, Z.S., Syed, M.S.S., Lech, M., Pirogova, E.: Automated recognition of alzheimer’s dementia using bag-of-deep-features and model ensembling. IEEE Access 9, 88377–88390 (2021) Syed, Z.S., Syed, M.S.S., Lech, M., Pirogova, E.: Automated recognition of alzheimer’s dementia using bag-of-deep-features and model ensembling. IEEE Access 9, 88377–88390 (2021)
137.
Zurück zum Zitat Orsulic-Jeras, S., Sanders, B., Powers, S., Ejaz, F., Cordell, A., Wilk, C.: Developing a reminiscence therapy platform-lifebio memorytm-with a novel machine-learning-based application that transfers speech to text and generates life stories for nursing home residents with dementia. Alzheimer’s & Dementia 17, 052281 (2021) Orsulic-Jeras, S., Sanders, B., Powers, S., Ejaz, F., Cordell, A., Wilk, C.: Developing a reminiscence therapy platform-lifebio memorytm-with a novel machine-learning-based application that transfers speech to text and generates life stories for nursing home residents with dementia. Alzheimer’s & Dementia 17, 052281 (2021)
138.
Zurück zum Zitat Sarawgi, U., Zulfikar, W., Soliman, N., Maes, P.: Multimodal inductive transfer learning for detection of alzheimer’s dementia and its severity. arXiv preprint arXiv:2009.00700 (2020) Sarawgi, U., Zulfikar, W., Soliman, N., Maes, P.: Multimodal inductive transfer learning for detection of alzheimer’s dementia and its severity. arXiv preprint arXiv:​2009.​00700 (2020)
139.
Zurück zum Zitat Calzà, L., Gagliardi, G., Favretti, R.R., Tamburini, F.: Linguistic features and automatic classifiers for identifying mild cognitive impairment and dementia. Computer Speech & Language 65, 101113 (2021) Calzà, L., Gagliardi, G., Favretti, R.R., Tamburini, F.: Linguistic features and automatic classifiers for identifying mild cognitive impairment and dementia. Computer Speech & Language 65, 101113 (2021)
140.
Zurück zum Zitat Haider, F., De La Fuente, S., Luz, S.: An assessment of paralinguistic acoustic features for detection of alzheimer’s dementia in spontaneous speech. IEEE Journal of Selected Topics in Signal Processing 14(2), 272–281 (2019) Haider, F., De La Fuente, S., Luz, S.: An assessment of paralinguistic acoustic features for detection of alzheimer’s dementia in spontaneous speech. IEEE Journal of Selected Topics in Signal Processing 14(2), 272–281 (2019)
141.
Zurück zum Zitat Lopez-de-Ipiña, K., Alonso, J.B., Solé-Casals, J., Barroso, N., Henriquez, P., Faundez-Zanuy, M., Travieso, C.M., Ecay-Torres, M., Martinez-Lage, P., Eguiraun, H.: On automatic diagnosis of alzheimer’s disease based on spontaneous speech analysis and emotional temperature. Cognitive Computation 7(1), 44–55 (2015) Lopez-de-Ipiña, K., Alonso, J.B., Solé-Casals, J., Barroso, N., Henriquez, P., Faundez-Zanuy, M., Travieso, C.M., Ecay-Torres, M., Martinez-Lage, P., Eguiraun, H.: On automatic diagnosis of alzheimer’s disease based on spontaneous speech analysis and emotional temperature. Cognitive Computation 7(1), 44–55 (2015)
142.
Zurück zum Zitat Orimaye, S.O., Wong, J.S.-M., Golden, K.J.: Learning predictive linguistic features for alzheimer’s disease and related dementias using verbal utterances. In: Proceedings of the Workshop on Computational Linguistics and Clinical Psychology: From Linguistic Signal to Clinical Reality, pp. 78–87 (2014) Orimaye, S.O., Wong, J.S.-M., Golden, K.J.: Learning predictive linguistic features for alzheimer’s disease and related dementias using verbal utterances. In: Proceedings of the Workshop on Computational Linguistics and Clinical Psychology: From Linguistic Signal to Clinical Reality, pp. 78–87 (2014)
143.
Zurück zum Zitat Santander-Cruz, Y., Salazar-Colores, S., Paredes-García, W.J., Guendulain-Arenas, H., Tovar-Arriaga, S.: Semantic feature extraction using sbert for dementia detection. Brain Sciences 12(2), 270 (2022) Santander-Cruz, Y., Salazar-Colores, S., Paredes-García, W.J., Guendulain-Arenas, H., Tovar-Arriaga, S.: Semantic feature extraction using sbert for dementia detection. Brain Sciences 12(2), 270 (2022)
Metadaten
Titel
Machine Learning for Dementia Prediction: A Systematic Review and Future Research Directions
verfasst von
Ashir Javeed
Ana Luiza Dallora
Johan Sanmartin Berglund
Arif Ali
Liaqata Ali
Peter Anderberg
Publikationsdatum
01.12.2023
Verlag
Springer US
Erschienen in
Journal of Medical Systems / Ausgabe 1/2023
Print ISSN: 0148-5598
Elektronische ISSN: 1573-689X
DOI
https://doi.org/10.1007/s10916-023-01906-7

Weitere Artikel der Ausgabe 1/2023

Journal of Medical Systems 1/2023 Zur Ausgabe